date timestamp[s]date 2026-11-02 00:00:00 2026-11-05 00:00:00 | rank int64 1 40 | ticker stringlengths 2 4 | name stringlengths 8 35 | cik int64 16.2k 2.05M | exchange stringclasses 2
values | sector stringlengths 10 57 | score float64 39.6 86.6 | cheap_score float64 0.28 0.94 | safe_score float64 0.35 0.97 | hated_price_score float64 0.11 0.98 | hated_score float64 0.14 0.92 | news_neg float64 0.2 1 | hate_why stringlengths 0 58 | first_seen stringclasses 1
value | return_since_first null | bonus listlengths 0 2 | flags listlengths 0 5 | price float64 1.04 148 | mcap float64 57.4M 12.3B | ev float64 -100,015,517.68 12.3B | dd_3y float64 -0.92 -0.41 | ret_1y float64 -0.78 2.89 | high_3y float64 3.02 511 | high_52w float64 2.85 381 | low_52w float64 1.04 148 | off_low float64 0 3.4 | pe float64 1.38 57.1 ⌀ | ev_ebit float64 0 21.1 ⌀ | pb float64 0.31 5.31 | earnings_yield float64 -0.3 0.72 | ebit_ev float64 -0.3 7 ⌀ | fcf_yield float64 -1.06 0.55 | book_yield float64 0.19 3.26 | ncav int64 -3,203,000,000 1.04B | netnet float64 -1.08 2.18 | net_cash int64 -5,146,000,000 669M | net_cash_pct float64 -1.29 2.61 | current_ratio float64 1.28 56.3 | liab_eq float64 0.03 1.82 | fcf int64 -65,777,000 1.12B | profit_years int64 0 3 | share_chg_3y float64 -0.75 0.42 ⌀ | rev_growth float64 -0.36 6.17 ⌀ | buyback_yield float64 0 1.94 ⌀ | div_yield float64 0 0.31 ⌀ | goodwill_pct float64 0 0.36 ⌀ | acq_pct float64 -0 0.75 ⌀ | period stringclasses 2
values | fy int64 2.03k 2.03k | assets int64 32.5M 14.8B | ca int64 27.9M 5.28B | cl int64 3.93M 3.02B | cash int64 6.18M 936M ⌀ | equity int64 27.7M 6.3B | goodwill int64 465k 5.27B ⌀ | debt int64 0 5.47B | debt_known bool 2
classes | liab int64 4.74M 8.49B | shares int64 2.87M 252M | shares_old int64 2.88M 268M ⌀ | shares_old_period stringclasses 1
value | ni float64 -19,000,000 1.58B | ni_1 float64 -187,353,000 1.81B ⌀ | ni_2 float64 -152,992,000 1.55B ⌀ | oi int64 -70,221,000 2.21B ⌀ | cfo int64 -65,777,000 1.6B | capex int64 0 681M ⌀ | buyback int64 0 1.18B ⌀ | dividends int64 0 1.99B ⌀ | acquisitions int64 -1,000,000 428M ⌀ | rev int64 21.5M 18.5B ⌀ | rev_1 int64 0 17.9B ⌀ | insider_buy_value float64 0 30.9M | insider_sell_value float64 0 2.99M | insider_buyers_count int64 0 11 | tenk_date timestamp[s]date 2025-11-21 00:00:00 2026-11-03 00:00:00 | tenk_accession stringlengths 20 20 | tenk_form stringclasses 2
values | tenk_url stringlengths 78 93 | ai_verdict stringclasses 3
values | ai_conviction int64 15 55 ⌀ | ai_balance_sheet stringclasses 4
values | ai_value_trap_risk stringclasses 3
values | ai_one_liner stringclasses 15
values |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-11-02T00:00:00 | 1 | KROS | Keros Therapeutics, Inc. | 1,664,710 | Nasdaq | Pharmaceutical Preparations | 79.4 | 0.7687 | 0.8319 | 0.7217 | 0.655 | 0.5 | null | [
"share count shrinking +4"
] | [
"earnings inconsistent",
"debt not tagged in XBRL: estimated from non-current liabilities",
"P/E under 3: check for one-off gains",
"net income well above operating profit"
] | 10.575 | 209,672,513.1 | -34,806,486.9 | -0.85 | -0.3472 | 70.48 | 21.69 | 10.06 | 0.0512 | 2.4096 | null | 0.7993 | 0.415 | null | 0.5053 | 1.2511 | 241,603,000 | 1.1523 | 244,479,000 | 1.166 | 21.9603 | 0.0964 | 105,954,000 | 1 | -0.3316 | null | 1.7885 | null | null | null | CY2026Q2I | 2,025 | 287,600,000 | 266,883,000 | 12,153,000 | 257,606,000 | 262,320,000 | null | 13,127,000 | false | 25,280,000 | 19,827,188 | 29,663,192 | CY2023Q2I | 87,014,000 | -187,353,000 | -152,992,000 | 67,569,000 | 107,505,000 | 1,551,000 | 375,000,000 | null | null | 243,864,000 | 0 | 0 | 0 | 1 | 2026-03-04T00:00:00 | 0001664710-26-000018 | 10-K | https://www.sec.gov/Archives/edgar/data/1664710/000166471026000018/kros-20251231.htm | WATCH | 45 | fortress | medium | Cash‑rich but still a pre‑revenue biotech; watch for trial readouts and dilution risk | ||
2026-11-02T00:00:00 | 2 | SIGA | SIGA TECHNOLOGIES INC | 1,010,086 | Nasdaq | Pharmaceutical Preparations | 79.3 | 0.7229 | 0.9696 | 0.8012 | 0.711 | 0.5 | null | [] | [
"revenue -32% y/y"
] | 2.915 | 209,441,922.14 | 94,458,323.14 | -0.7229 | -0.6546 | 10.52 | 8.28 | 2.915 | 0 | 8.997 | 3.9852 | 1.2671 | 0.1111 | 0.2509 | 0.2076 | 0.7892 | 159,931,631 | 0.7636 | 114,983,599 | 0.549 | 21.7172 | 0.0632 | 43,471,453 | 3 | 0.0108 | -0.3182 | 0 | 0.2059 | 0.0051 | null | CY2026Q2I | 2,025 | 175,736,786 | 170,377,782 | 7,845,306 | 117,584,444 | 165,290,635 | 898,334 | 2,600,845 | false | 10,446,151 | 71,849,716 | 71,082,944 | CY2023Q2I | 23,279,143 | 59,214,216 | 68,068,826 | 23,702,156 | 43,471,453 | null | 0 | 43,116,529 | null | 94,574,902 | 138,719,350 | 0 | 0 | 0 | 2026-03-10T00:00:00 | 0001437749-26-007557 | 10-K | https://www.sec.gov/Archives/edgar/data/1010086/000143774926007557/siga20251231_10k.htm | WATCH | 55 | fortress | medium | Cash‑rich, single‑product govt play—big upside if contract rolls, but regulatory and renewal risk loom. | ||
2026-11-02T00:00:00 | 3 | CRTO | Criteo S.A. | 1,576,427 | Nasdaq | Services-Advertising Agencies | 68.7 | 0.7593 | 0.6174 | 0.5371 | 0.526 | 0.5 | null | [
"share count shrinking +4"
] | [] | 14.89 | 729,573,653.51 | 646,275,653.51 | -0.698 | -0.3049 | 49.3 | 22.88 | 14.65 | 0.0164 | 4.8965 | 3.1873 | 0.6471 | 0.2042 | 0.3137 | 0.2858 | 1.5454 | 26,419,000 | 0.0362 | 83,298,000 | 0.1142 | 1.2883 | 0.7509 | 208,498,000 | 3 | -0.1221 | 0.006 | 0.2084 | null | 0.2645 | 0 | CY2026Q2I | 2,025 | 2,010,784,000 | 873,072,000 | 677,715,000 | 252,236,000 | 1,127,515,000 | 531,794,000 | 168,938,000 | false | 846,653,000 | 48,997,559 | 55,812,266 | CY2023Q2I | 149,000,000 | 115,000,000 | 55,000,000 | 202,765,000 | 311,237,000 | 102,739,000 | 152,064,000 | null | 0 | 1,944,901,000 | 1,933,289,000 | 0 | 642,246.33 | 0 | 2026-02-26T00:00:00 | 0001576427-26-000014 | 10-K | https://www.sec.gov/Archives/edgar/data/1576427/000157642726000014/crto-20251231.htm | WATCH | 55 | solid | medium | Deeply discounted ad tech with cash moat, but flat growth and execution risk keep it cautious. | ||
2026-11-02T00:00:00 | 4 | NUS | NU SKIN ENTERPRISES, INC. | 1,021,561 | NYSE | Wholesale-Drugs, Proprietaries & Druggists' Sundries | 66.6 | 0.7756 | 0.5159 | 0.7447 | 0.671 | 0.5 | null | [] | [
"P/E under 3: check for one-off gains"
] | 4.789 | 233,112,400.226 | 257,133,400.226 | -0.7534 | -0.4749 | 19.42 | 11.54 | 4.58 | 0.0456 | 1.4551 | 3.91 | 0.4295 | 0.6872 | 0.2558 | 0.1974 | 2.3282 | -70,642,000 | -0.303 | -24,021,000 | -0.103 | 1.9823 | 1.0664 | 46,009,000 | 2 | -0.0257 | -0.1426 | 0.086 | null | 0.0042 | 0 | CY2026Q2I | 2,025 | 1,121,530,000 | 508,149,000 | 256,347,000 | 189,643,000 | 542,739,000 | 4,750,000 | 213,664,000 | true | 578,791,000 | 48,676,634 | 49,958,985 | CY2023Q2I | 160,204,000 | -146,594,000 | 8,595,000 | 65,763,000 | 80,286,000 | 34,277,000 | 20,040,000 | null | 0 | 1,485,159,000 | 1,732,084,000 | 0 | 18,009.48 | 0 | 2026-02-13T00:00:00 | 0001140361-26-005130 | 10-K | https://www.sec.gov/Archives/edgar/data/1021561/000114036126005130/ef20060638_10k.htm | AVOID | 15 | stretched | high | Cheap price but fragile earnings, leverage and MLM risks outweigh cash cushion. | ||
2026-11-02T00:00:00 | 5 | USNA | USANA HEALTH SCIENCES INC | 896,264 | NYSE | Medicinal Chemicals & Botanical Products | 65 | 0.6283 | 0.8304 | 0.4995 | 0.5 | 0.5 | null | [] | [] | 14.71 | 271,789,815.14 | 129,791,815.14 | -0.7256 | -0.2311 | 53.6 | 22.53 | 13.37 | 0.1002 | 25.2593 | 3.4674 | 0.5164 | 0.0396 | 0.2884 | 0.0314 | 1.9364 | 148,829,000 | 0.5476 | 141,998,000 | 0.5225 | 2.6597 | 0.2513 | 8,526,000 | 3 | -0.0428 | 0.0828 | 0.1012 | null | 0.1552 | 0 | CY2026Q2I | 2,025 | 703,210,000 | 281,066,000 | 105,675,000 | 168,560,000 | 526,306,000 | 109,141,000 | 26,562,000 | false | 132,237,000 | 18,476,534 | 19,301,730 | CY2023Q2I | 10,760,000 | 42,030,000 | 63,788,000 | 37,432,000 | 22,349,000 | 13,823,000 | 27,507,000 | null | 0 | 925,257,000 | 854,503,000 | 0 | 426,891.595 | 0 | 2026-03-16T00:00:00 | 0000896264-26-000021 | 10-K | https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm | WATCH | 55 | fortress | medium | Cash‑rich, cheap but China‑centric direct‑selling risks keep it a cautious watch. | ||
2026-11-02T00:00:00 | 6 | SMPL | Simply Good Foods Co | 1,702,744 | Nasdaq | Food and Kindred Products | 63.9 | 0.5106 | 0.7174 | 0.6198 | 0.599 | 0.55 | null | [
"share count shrinking +4"
] | [] | 12.325 | 1,070,573,743.275 | 1,279,367,743.275 | -0.7046 | -0.3834 | 41.72 | 21.4 | 9.6 | 0.2839 | 10.3323 | 8.1547 | 0.7371 | 0.0968 | 0.1226 | 0.1475 | 1.3567 | -150,796,000 | -0.1409 | -208,794,000 | -0.195 | 5.5744 | 0.4023 | 157,915,000 | 3 | -0.1274 | 0.0898 | 0.0475 | null | 0.271 | 0.0016 | CY2026Q3I | 2,025 | 2,036,744,000 | 433,540,000 | 77,773,000 | 138,425,000 | 1,452,408,000 | 551,974,000 | 347,219,000 | true | 584,336,000 | 86,861,967 | 99,548,989 | CY2023Q2I | 103,614,000 | 139,309,000 | 133,575,000 | 156,887,000 | 178,457,000 | 20,542,000 | 50,886,000 | null | 1,713,000 | 1,450,920,000 | 1,331,321,000 | 0 | 0 | 1 | 2026-10-27T00:00:00 | 0001702744-26-000031 | 10-K | https://www.sec.gov/Archives/edgar/data/1702744/000170274426000031/atk-20260829.htm | WATCH | 45 | solid | medium | Cheap, cash‑rich snack maker but brand‑driven sales slump raises a medium‑risk flag. | ||
2026-11-02T00:00:00 | 7 | HDSN | HUDSON TECHNOLOGIES INC /NY | 925,528 | Nasdaq | Wholesale-Machinery, Equipment & Supplies | 63.7 | 0.5302 | 0.5652 | 0.6427 | 0.66 | 0.7 | null | [
"insider buying +8",
"share count shrinking +4"
] | [
"profits not backed by cash flow"
] | 4.205 | 176,982,340.135 | 162,673,340.135 | -0.7166 | -0.3861 | 14.84 | 7.48 | 4.205 | 0 | 10.6187 | 8.7652 | 0.7275 | 0.0942 | 0.1141 | -0.0464 | 1.3745 | 139,354,000 | 0.7874 | 14,309,000 | 0.0808 | 3.2315 | 0.3239 | -8,214,000 | 3 | -0.0728 | null | 0.1131 | null | 0.2027 | null | CY2026Q2I | 2,025 | 322,063,000 | 218,153,000 | 67,508,000 | 25,600,000 | 243,264,000 | 65,282,000 | 11,291,000 | false | 78,799,000 | 42,088,547 | 45,395,085 | CY2023Q2I | 16,667,000 | 24,388,000 | 52,247,000 | 18,559,000 | -3,162,000 | 5,052,000 | 20,014,000 | null | null | null | 237,118,000 | 725,222.97 | 0 | 9 | 2026-03-16T00:00:00 | 0001104659-26-028445 | 10-K | https://www.sec.gov/Archives/edgar/data/925528/000110465926028445/hdsn-20251231x10k.htm | WATCH | 55 | solid | medium | Cheap, cash‑rich refrigerant specialist facing commodity and regulatory headwinds. | ||
2026-11-02T00:00:00 | 8 | AMPY | Amplify Energy Corp. | 1,533,924 | NYSE | Crude Petroleum & Natural Gas | 63.7 | 0.7859 | 0.5783 | 0.2083 | 0.296 | 0.5 | null | [
"insider buying +6"
] | [
"debt not tagged in XBRL: estimated from non-current liabilities"
] | 3.898 | 161,597,242.1 | 227,113,242.1 | -0.4996 | -0.1414 | 7.79 | 6.56 | 3.898 | 0 | 3.6753 | 2.9518 | 0.368 | 0.2721 | 0.3388 | 0.3045 | 2.7172 | -71,298,000 | -0.4412 | -65,516,000 | -0.4054 | 1.3069 | 0.312 | 49,200,000 | 3 | 0.0613 | -0.1063 | null | null | null | null | CY2026Q2I | 2,025 | 576,094,000 | 65,709,000 | 50,279,000 | 21,212,000 | 439,087,000 | null | 86,728,000 | false | 137,007,000 | 41,456,450 | 39,062,303 | CY2023Q2I | 43,968,000 | 12,946,000 | 392,750,000 | 76,940,000 | 49,200,000 | null | null | null | null | 263,361,000 | 294,681,000 | 98,750 | 0 | 1 | 2026-03-09T00:00:00 | 0001104659-26-025299 | 10-K | https://www.sec.gov/Archives/edgar/data/1533924/000110465926025299/ampy-20251231x10k.htm | AVOID | 15 | stretched | high | Deeply discounted but burdened by debt, shrinking reserves and high commodity risk. | ||
2026-11-02T00:00:00 | 9 | MED | MEDIFAST INC | 910,329 | NYSE | Miscellaneous Food Preparations & Kindred Products | 63.6 | 0.4113 | 0.7551 | 0.5095 | 0.537 | 0.6 | null | [
"insider buying +8"
] | [
"revenue -36% y/y"
] | 12.462 | 139,357,523.814 | 98,595,523.814 | -0.8334 | 0.0446 | 74.81 | 12.63 | 9.62 | 0.2954 | null | null | 0.773 | -0.1363 | -0.1442 | 0.009 | 1.2936 | 142,449,000 | 1.0222 | 40,762,000 | 0.2925 | 4.8222 | 0.33 | 1,249,000 | 2 | 0.0269 | -0.3596 | 0 | 0.0014 | null | null | CY2026Q3I | 2,025 | 239,763,000 | 201,935,000 | 41,876,000 | 58,372,000 | 180,277,000 | null | 17,610,000 | false | 59,486,000 | 11,182,597 | 10,889,368 | CY2023Q2I | -19,000,000 | 2,000,000 | 99,000,000 | -14,213,000 | 6,863,000 | 5,614,000 | 0 | 195,000 | null | 385,788,000 | 602,463,000 | 1,554,779.1415 | 0 | 2 | 2026-02-17T00:00:00 | 0001628280-26-008656 | 10-K | https://www.sec.gov/Archives/edgar/data/910329/000162828026008656/med-20251231.htm | WATCH | 55 | fortress | medium | Cash‑rich but earnings volatile; transformation success critical for upside | ||
2026-11-02T00:00:00 | 10 | LFVN | Lifevantage Corp | 849,146 | Nasdaq | Pharmaceutical Preparations | 62.5 | 0.5122 | 0.5826 | 0.5155 | 0.661 | 1 | null | [
"insider buying +5"
] | [] | 5.99 | 75,038,814.52 | 83,333,814.52 | -0.7633 | -0.1905 | 25.31 | 9.97 | 4.15 | 0.4434 | 7.6531 | 6.8312 | 2.234 | 0.1307 | 0.1464 | 0.14 | 0.4476 | 9,775,000 | 0.1303 | -8,295,000 | -0.1105 | 1.8934 | 0.8491 | 10,507,000 | 3 | null | 0.1417 | 0.0419 | 0.0275 | 0.0075 | null | CY2026Q2I | 2,025 | 62,111,000 | 38,297,000 | 20,227,000 | null | 33,589,000 | 465,000 | 8,295,000 | false | 28,522,000 | 12,527,348 | null | CY2023Q2I | 9,805,000 | 2,937,000 | 2,540,000 | 12,199,000 | 11,878,000 | 1,371,000 | 3,147,000 | 2,067,000 | null | 228,530,000 | 200,164,000 | 12,130.195 | 641 | 1 | 2026-08-27T00:00:00 | 0001193125-26-371257 | 10-K | https://www.sec.gov/Archives/edgar/data/849146/000119312526371257/lfvn-20260630.htm | WATCH | 45 | solid | medium | Low‑debt, cash‑generating but consultant‑driven model and dilution risk keep it a cautious watch. | ||
2026-11-02T00:00:00 | 11 | PEW | GrabAGun Digital Holdings Inc. | 2,051,380 | NYSE | Retail-Miscellaneous Shopping Goods Stores | 62.1 | 0.4557 | 0.6681 | 0.9434 | 0.795 | 0.45 | null | [] | [] | 1.948 | 57,492,177.224 | -32,354,822.776 | -0.8869 | -0.5992 | 17.22 | 4.6 | 1.84 | 0.0587 | null | null | 0.5605 | -0.0436 | null | -0.1546 | 1.784 | 89,135,000 | 1.5504 | 89,847,000 | 1.5628 | 9.4247 | 0.1868 | -8,890,000 | 2 | null | 0.0357 | null | null | null | null | CY2026Q2I | 2,025 | 121,719,000 | 108,290,000 | 11,490,000 | 97,512,000 | 102,564,000 | null | 7,665,000 | true | 19,155,000 | 29,513,438 | null | CY2023Q2I | -2,507,000 | 4,509,000 | 4,519,000 | -4,364,000 | -417,000 | 8,473,000 | null | null | null | 96,449,000 | 93,122,000 | 0 | 0 | 0 | 2026-03-12T00:00:00 | 0001193125-26-104172 | 10-K | https://www.sec.gov/Archives/edgar/data/2051380/000119312526104172/pew-20251231.htm | null | ||||||
2026-11-02T00:00:00 | 12 | LULU | lululemon athletica inc. | 1,397,187 | Nasdaq | Apparel & Other Finishd Prods of Fabrics & Similar Matl | 61.3 | 0.4817 | 0.6391 | 0.6829 | 0.628 | 0.5 | null | [
"share count shrinking +4"
] | [] | 107.68 | 11,676,599,209.76 | 11,676,599,209.76 | -0.7894 | -0.3518 | 511.29 | 210.81 | 94.46 | 0.14 | 7.3941 | 5.2821 | 2.4371 | 0.1352 | 0.1893 | 0.0789 | 0.4103 | 252,183,000 | 0.0216 | 0 | 0 | 2.19 | 0.7709 | 921,675,000 | 3 | -0.1108 | 0.0486 | 0.1009 | null | 0.0219 | 0 | CY2026Q2I | 2,025 | 8,484,578,000 | 3,945,587,000 | 1,801,651,000 | null | 4,791,174,000 | 185,840,000 | 0 | true | 3,693,404,000 | 108,437,957 | 121,949,471 | CY2023Q2I | 1,579,183,000 | 1,814,616,000 | 1,550,190,000 | 2,210,615,000 | 1,602,477,000 | 680,802,000 | 1,178,349,000 | null | 0 | 11,102,600,000 | 10,588,126,000 | 0 | 0 | 1 | 2026-03-17T00:00:00 | 0001397187-26-000020 | 10-K | https://www.sec.gov/Archives/edgar/data/1397187/000139718726000020/lulu-20260201.htm | null | ||||||
2026-11-02T00:00:00 | 13 | NAGE | Niagen Bioscience, Inc. | 1,386,570 | Nasdaq | Medicinal Chemicals & Botanical Products | 59.7 | 0.3782 | 0.7072 | 0.8993 | 0.78 | 0.5 | null | [] | [
"debt not tagged in XBRL: estimated from non-current liabilities"
] | 2.39 | 189,111,144.78 | 198,122,144.78 | -0.8319 | -0.6506 | 14.22 | 6.88 | 2.33 | 0.0258 | 10.8797 | 12.1704 | 2.2915 | 0.0919 | 0.0822 | 0.0714 | 0.4364 | 73,725,000 | 0.3899 | -9,011,000 | -0.0476 | 6.4974 | 0.2915 | 13,504,000 | 2 | 0.0546 | 0.2995 | 0.0013 | null | null | null | CY2026Q2I | 2,025 | 106,589,000 | 97,786,000 | 15,050,000 | null | 82,528,000 | null | 9,011,000 | false | 24,061,000 | 79,126,002 | 75,032,367 | CY2023Q2I | 17,382,000 | 8,550,000 | -4,938,000 | 16,279,000 | 13,504,000 | null | 251,000 | null | null | 129,423,000 | 99,597,000 | 0 | 0 | 0 | 2026-03-04T00:00:00 | 0001386570-26-000013 | 10-K | https://www.sec.gov/Archives/edgar/data/1386570/000138657026000013/cdxc-20251231.htm | null | ||||||
2026-11-02T00:00:00 | 14 | BYRN | Byrna Technologies Inc. | 1,354,866 | Nasdaq | Miscellaneous Electrical Machinery, Equipment & Supplies | 59.5 | 0.4242 | 0.5638 | 0.9622 | 0.861 | 0.625 | null | [
"insider buying +6"
] | [
"profits not backed by cash flow"
] | 4.21 | 98,534,014.34 | 91,315,014.34 | -0.8731 | -0.7717 | 33.18 | 19.67 | 3.34 | 0.2605 | 10.1718 | 7.7137 | 1.7877 | 0.0983 | 0.1296 | -0.0933 | 0.5594 | 36,288,000 | 0.3683 | 7,219,000 | 0.0733 | 5.5356 | 0.1717 | -9,195,000 | 2 | 0.065 | 0.3774 | 0.0112 | null | 0.042 | null | CY2026Q3I | 2,025 | 64,583,000 | 45,752,000 | 8,265,000 | 8,418,000 | 55,119,000 | 2,714,000 | 1,199,000 | false | 9,464,000 | 23,404,754 | 21,977,027 | CY2023Q2I | 9,687,000 | 12,792,000 | -8,192,000 | 11,838,000 | -1,572,000 | 7,623,000 | 1,102,000 | null | null | 118,120,000 | 85,756,000 | 70,375 | 0 | 7 | 2026-02-05T00:00:00 | 0001437749-26-003206 | 10-K | https://www.sec.gov/Archives/edgar/data/1354866/000143774926003206/byrn20251130_10k.htm | null | ||||||
2026-11-02T00:00:00 | 15 | IMXI | International Money Express, Inc. | 1,683,695 | Nasdaq | Services-Business Services, NEC | 59.4 | 0.5093 | 0.6174 | 0.4852 | 0.55 | 0.7 | null | [
"share count shrinking +4"
] | [] | 9.57 | 289,125,270.39 | 252,303,270.39 | -0.5808 | -0.3679 | 22.83 | 15.94 | 9.16 | 0.0448 | 8.8496 | 4.5338 | 1.7053 | 0.113 | 0.2206 | 0.0547 | 0.5864 | 5,646,000 | 0.0195 | 36,822,000 | 0.1274 | 1.9594 | 1.652 | 15,813,000 | 3 | -0.147 | null | 0.0565 | null | 0.1201 | 0 | CY2026Q2I | 2,025 | 449,641,000 | 285,737,000 | 145,831,000 | 150,636,000 | 169,550,000 | 53,986,000 | 113,814,000 | true | 280,091,000 | 30,211,627 | 35,418,293 | CY2023Q2I | 32,671,000 | 58,821,000 | 59,515,000 | 55,650,000 | 36,887,000 | 21,074,000 | 16,334,000 | null | 0 | null | null | 0 | 0 | 0 | 2026-03-06T00:00:00 | 0001628280-26-015647 | 10-K | https://www.sec.gov/Archives/edgar/data/1683695/000162828026015647/imxi-20251231.htm | null | ||||||
2026-11-02T00:00:00 | 16 | YELP | YELP INC | 1,345,016 | NYSE | Services-Personal Services | 59.1 | 0.592 | 0.6174 | 0.4438 | 0.431 | 0.4 | null | [
"share count shrinking +4"
] | [
"debt not tagged in XBRL: estimated from non-current liabilities"
] | 19.67 | 1,067,365,425.07 | 1,151,414,425.07 | -0.5938 | -0.3196 | 48.43 | 31.3 | 18.03 | 0.091 | 7.3308 | 6.24 | 1.656 | 0.1364 | 0.1603 | 0.3032 | 0.6038 | -52,537,000 | -0.0492 | -84,049,000 | -0.0787 | 1.7486 | 0.5369 | 323,676,000 | 3 | -0.2103 | 0.0375 | 0.2726 | null | 0.3581 | 0 | CY2026Q2I | 2,025 | 990,565,000 | 293,501,000 | 167,847,000 | 94,142,000 | 644,527,000 | 354,708,000 | 178,191,000 | false | 346,038,000 | 54,263,621 | 68,713,576 | CY2023Q2I | 145,600,000 | 132,850,000 | 99,173,000 | 184,521,000 | 372,029,000 | 48,353,000 | 290,949,000 | null | 0 | 1,464,955,000 | 1,412,064,000 | 0 | 0 | 0 | 2026-02-27T00:00:00 | 0001345016-26-000019 | 10-K | https://www.sec.gov/Archives/edgar/data/1345016/000134501626000019/yelp-20251231.htm | null | ||||||
2026-11-02T00:00:00 | 17 | PLAB | PHOTRONICS INC | 810,136 | Nasdaq | Semiconductors & Related Devices | 57.9 | 0.5213 | 0.8609 | 0.1305 | 0.241 | 0.5 | null | [
"share count shrinking +4"
] | [] | 27.515 | 1,622,386,150.47 | 1,076,766,150.47 | -0.487 | 0.2674 | 53.64 | 53.64 | 21.06 | 0.3065 | 11.8939 | 5.1728 | 1.2668 | 0.0841 | 0.1933 | 0.0368 | 0.7894 | 727,815,000 | 0.4486 | 545,620,000 | 0.3363 | 4.9414 | 0.1929 | 59,661,000 | 3 | -0.0569 | -0.0204 | 0.06 | null | null | null | CY2026Q2I | 2,025 | 1,990,743,000 | 974,856,000 | 197,283,000 | 549,513,000 | 1,280,694,000 | null | 3,893,000 | true | 247,041,000 | 58,963,698 | 62,518,181 | CY2023Q2I | 136,405,000 | 130,688,000 | 125,485,000 | 208,161,000 | 247,798,000 | 188,137,000 | 97,422,000 | null | null | 849,294,000 | 866,946,000 | 0 | 806,765 | 0 | 2025-12-17T00:00:00 | 0001140361-25-045801 | 10-K | https://www.sec.gov/Archives/edgar/data/810136/000114036125045801/ef20057458_10k.htm | null | ||||||
2026-11-02T00:00:00 | 18 | EGAN | EGAIN Corp | 1,066,194 | Nasdaq | Services-Prepackaged Software | 57.8 | 0.4467 | 0.6957 | 0.6384 | 0.634 | 0.625 | null | [] | [
"net income well above operating profit"
] | 5.88 | 153,888,225.96 | 85,247,225.96 | -0.5928 | -0.5922 | 14.44 | 12.14 | 5.26 | 0.1179 | 4.7711 | 19.2301 | 1.8274 | 0.2096 | 0.052 | 0.0305 | 0.5472 | 38,209,000 | 0.2483 | 68,641,000 | 0.446 | 1.7261 | 0.7574 | 4,698,000 | 3 | null | -0.0471 | 0.1025 | null | 0.0891 | null | CY2026Q2I | 2,025 | 147,995,000 | 101,991,000 | 59,087,000 | 73,336,000 | 84,213,000 | 13,186,000 | 4,695,000 | false | 63,782,000 | 26,171,467 | null | CY2023Q2I | 32,254,000 | 7,780,000 | 2,109,000 | 4,433,000 | 5,263,000 | 565,000 | 15,781,000 | null | null | 88,431,000 | 92,803,000 | 0 | 0 | 0 | 2026-09-10T00:00:00 | 0001104659-26-106739 | 10-K | https://www.sec.gov/Archives/edgar/data/1066194/000110465926106739/egan-20260630x10k.htm | null | ||||||
2026-11-02T00:00:00 | 19 | CUVL | Clinuvel Pharmaceuticals Ltd | 1,290,877 | Nasdaq | American Depositary Receipts | 57.2 | 0.5036 | 0.8029 | 0.4045 | 0.433 | 0.5 | null | [] | [] | 5 | 252,139,490 | 240,235,698 | -0.5763 | -0.2978 | 11.8 | 8.75 | 4.94 | 0.0121 | 10.9043 | 9.0586 | 1.3368 | 0.0917 | 0.1104 | 0.1075 | 0.7481 | 181,163,684 | 0.7185 | 11,903,792 | 0.0472 | 14.7186 | 0.0815 | 27,104,961 | 2 | null | 0.0554 | 0.0007 | 0.0067 | null | null | CY2026Q2I | 2,025 | 203,983,448 | 196,527,135 | 13,352,290 | 13,914,953 | 188,619,997 | null | 2,011,161 | false | 15,363,451 | 50,427,898 | null | CY2023Q2I | 23,122,864 | 23,346,174 | null | 26,520,057 | 27,295,554 | 190,593 | 173,965 | 1,693,879 | null | 61,120,888 | 57,911,843 | 0 | 0 | 0 | 2026-10-30T00:00:00 | 0001493152-26-049364 | 20-F | https://www.sec.gov/Archives/edgar/data/1290877/000149315226049364/form20-f.htm | null | ||||||
2026-11-02T00:00:00 | 20 | LRN | Stride, Inc. | 1,157,408 | NYSE | Services-Educational Services | 57.2 | 0.4313 | 0.6957 | 0.1974 | 0.303 | 0.55 | null | [
"insider buying +10"
] | [] | 77.276 | 3,249,367,164.428 | 3,120,048,164.428 | -0.5321 | 0.0731 | 165.17 | 100.01 | 62.68 | 0.2329 | 11.2848 | 8.6645 | 1.9437 | 0.0886 | 0.1154 | 0.1327 | 0.5145 | 895,216,000 | 0.2755 | 129,319,000 | 0.0398 | 2.559 | 0.5139 | 431,035,000 | 3 | -0.022 | 0.179 | null | null | 0.0975 | null | CY2026Q3I | 2,025 | 2,530,956,000 | 1,754,407,000 | 685,589,000 | 547,750,000 | 1,671,765,000 | 246,676,000 | 418,431,000 | true | 859,191,000 | 42,048,853 | 42,992,835 | CY2023Q2I | 287,941,000 | 204,183,000 | 126,867,000 | 360,094,000 | 432,816,000 | 1,781,000 | null | null | null | 2,405,317,000 | 2,040,069,000 | 12,240,309.84 | 0 | 1 | 2026-08-05T00:00:00 | 0001104659-26-090515 | 10-K | https://www.sec.gov/Archives/edgar/data/1157408/000110465926090515/lrn-20260630x10k.htm | null | ||||||
2026-11-02T00:00:00 | 21 | SMID | SMITH MIDLAND CORP | 924,719 | Nasdaq | Concrete Products, Except Block & Brick | 57.1 | 0.4204 | 0.713 | 0.4646 | 0.475 | 0.5 | null | [
"insider buying +5"
] | [] | 23.195 | 123,085,520.03 | 126,560,520.03 | -0.5276 | -0.3896 | 49.1 | 38.41 | 21.29 | 0.0895 | 9.8421 | 7.4474 | 2.1579 | 0.1016 | 0.1343 | 0.0403 | 0.4634 | 16,430,000 | 0.1335 | -3,475,000 | -0.0282 | 4.0603 | 0.5199 | 4,963,000 | 3 | null | 0.1903 | null | null | null | null | CY2026Q2I | 2,025 | 86,693,000 | 46,084,000 | 11,350,000 | null | 57,039,000 | null | 3,475,000 | true | 29,654,000 | 5,306,554 | null | CY2023Q2I | 12,506,000 | 7,675,000 | 795,000 | 16,994,000 | 14,301,000 | 9,338,000 | null | null | null | 93,446,000 | 78,508,000 | 9,804.75 | 0 | 1 | 2026-04-14T00:00:00 | 0001654954-26-003505 | 10-K | https://www.sec.gov/Archives/edgar/data/924719/000165495426003505/smid_10k.htm | null | ||||||
2026-11-02T00:00:00 | 22 | CRMD | CorMedix Inc. | 1,410,098 | Nasdaq | Pharmaceutical Preparations | 56.8 | 0.7821 | 0.5014 | 0.6452 | 0.617 | 0.55 | null | [] | [
"dilution 42% in 3y",
"earnings inconsistent",
"debt not tagged in XBRL: estimated from non-current liabilities",
"P/E under 3: check for one-off gains"
] | 5.455 | 425,186,287.42 | 424,317,287.42 | -0.6322 | -0.493 | 14.83 | 12.53 | 5.455 | 0 | 2.6076 | 2.8261 | 0.9226 | 0.3835 | 0.3538 | 0.4064 | 1.0838 | 37,335,000 | 0.0878 | 869,000 | 0.002 | 2.5644 | 0.9618 | 172,786,000 | 1 | 0.4222 | 6.1703 | null | null | 0.0332 | 0.7256 | CY2026Q2I | 2,025 | 904,052,000 | 480,554,000 | 187,396,000 | 256,692,000 | 460,833,000 | 30,002,000 | 255,823,000 | false | 443,219,000 | 77,944,324 | 54,805,376 | CY2023Q2I | 163,055,000 | -17,930,000 | -46,339,000 | 150,141,000 | 175,046,000 | 2,260,000 | null | null | 308,511,000 | 311,709,000 | 43,472,000 | 0 | 0 | 0 | 2026-03-05T00:00:00 | 0001213900-26-023889 | 10-K | https://www.sec.gov/Archives/edgar/data/1410098/000121390026023889/ea0278169-10k_cormedix.htm | null | ||||||
2026-11-02T00:00:00 | 23 | SPRO | Spero Therapeutics, Inc. | 1,701,108 | Nasdaq | Pharmaceutical Preparations | 56.5 | 0.613 | 0.6333 | 0.6904 | 0.633 | 0.5 | null | [] | [
"profits not backed by cash flow"
] | 1.04 | 60,564,220.08 | 9,924,220.08 | -0.6556 | -0.572 | 3.02 | 2.85 | 1.04 | 0 | 7.0654 | 1.5718 | 1.3701 | 0.1415 | 0.6362 | -0.2084 | 0.7299 | 43,022,000 | 0.7104 | 50,640,000 | 0.8361 | 6.1206 | 0.1937 | -12,624,000 | 2 | 0.1051 | 0.3924 | null | null | null | null | CY2026Q2I | 2,025 | 52,766,000 | 51,584,000 | 8,428,000 | 50,774,000 | 44,204,000 | null | 134,000 | false | 8,562,000 | 58,234,827 | 52,696,289 | CY2023Q2I | 8,572,000 | -68,566,000 | 22,806,000 | 6,314,000 | -12,624,000 | null | null | null | null | 66,802,000 | 47,977,000 | 0 | 0 | 0 | 2026-03-26T00:00:00 | 0001193125-26-126192 | 10-K | https://www.sec.gov/Archives/edgar/data/1701108/000119312526126192/spro-20251231.htm | null | ||||||
2026-11-02T00:00:00 | 24 | MDXG | MIMEDX GROUP, INC. | 1,376,339 | Nasdaq | Surgical & Medical Instruments & Apparatus | 56.2 | 0.5203 | 0.8217 | 0.6789 | 0.625 | 0.5 | null | [] | [
"dilution 26% in 3y"
] | 3.34 | 487,391,473.94 | 366,600,473.94 | -0.655 | -0.5511 | 9.68 | 7.38 | 3.34 | 0 | 10.0332 | 5.7383 | 2.309 | 0.0997 | 0.1743 | 0.1518 | 0.4331 | 133,763,000 | 0.2744 | 120,791,000 | 0.2478 | 4.3511 | 0.2533 | 74,003,000 | 3 | 0.2568 | 0.1999 | 0 | null | 0.0735 | null | CY2026Q3I | 2,025 | 264,552,000 | 187,233,000 | 43,031,000 | 120,791,000 | 211,082,000 | 19,441,000 | 0 | true | 53,470,000 | 145,925,591 | 116,109,125 | CY2023Q2I | 48,578,000 | 42,419,000 | 58,228,000 | 63,887,000 | 74,003,000 | null | 0 | null | null | 418,630,000 | 348,879,000 | 0 | 0 | 0 | 2026-02-25T00:00:00 | 0001376339-26-000011 | 10-K | https://www.sec.gov/Archives/edgar/data/1376339/000137633926000011/mdxg-20251231.htm | null | ||||||
2026-11-02T00:00:00 | 25 | UPWK | UPWORK, INC | 1,627,475 | Nasdaq | Services-Computer Processing & Data Preparation | 55.5 | 0.4612 | 0.587 | 0.5191 | 0.513 | 0.5 | null | [
"share count shrinking +4"
] | [] | 9.96 | 1,244,037,515.4 | 1,128,688,515.4 | -0.5495 | -0.4292 | 22.11 | 22.11 | 8.05 | 0.2373 | 10.7779 | 8.7288 | 2.0352 | 0.0928 | 0.1146 | 0.1949 | 0.4914 | 245,852,000 | 0.1976 | 115,349,000 | 0.0927 | 1.4242 | 1.0849 | 242,469,000 | 3 | -0.074 | 0.024 | 0.1093 | null | 0.1171 | 0.0469 | CY2026Q2I | 2,025 | 1,274,404,000 | 908,990,000 | 638,249,000 | 476,040,000 | 611,266,000 | 149,192,000 | 360,691,000 | true | 663,138,000 | 124,903,365 | 134,883,597 | CY2023Q2I | 115,425,000 | 215,586,000 | 46,887,000 | 129,307,000 | 248,259,000 | 5,790,000 | 135,959,000 | null | 58,406,000 | 787,784,000 | 769,325,000 | 0 | 0 | 0 | 2026-02-13T00:00:00 | 0001627475-26-000012 | 10-K | https://www.sec.gov/Archives/edgar/data/1627475/000162747526000012/upwk-20251231.htm | null | ||||||
2026-11-02T00:00:00 | 26 | CALM | CAL-MAINE FOODS INC | 16,160 | Nasdaq | Agricultural Prod-Livestock & Animal Specialties | 54.9 | 0.5335 | 0.813 | 0.2224 | 0.306 | 0.5 | null | [] | [
"debt not tagged in XBRL: estimated from non-current liabilities",
"revenue -32% y/y"
] | 65.26 | 3,048,334,604.38 | 3,177,097,604.38 | -0.4376 | -0.2644 | 116.04 | 90.47 | 62.6 | 0.0425 | 9.6259 | 9.0726 | 1.1862 | 0.1039 | 0.1102 | 0.1078 | 0.843 | 1,038,461,000 | 0.3407 | -128,763,000 | -0.0422 | 7.7011 | 0.1687 | 328,533,000 | 3 | null | -0.3168 | null | 0.076 | 0.0322 | 0.1403 | CY2026Q3I | 2,025 | 3,013,379,000 | 1,471,893,000 | 191,127,000 | 113,542,000 | 2,569,736,000 | 97,059,000 | 242,305,000 | false | 433,432,000 | 46,710,613 | null | CY2023Q2I | 316,682,000 | 1,220,048,000 | 277,888,000 | 350,186,000 | 479,753,000 | 151,220,000 | null | 231,622,000 | 427,794,000 | 2,911,632,000 | 4,261,885,000 | 0 | 0 | 0 | 2026-07-22T00:00:00 | 0001562762-26-000080 | 10-K | https://www.sec.gov/Archives/edgar/data/16160/000156276226000080/calm2026053010K.htm | null | ||||||
2026-11-02T00:00:00 | 27 | LKQ | LKQ CORP | 1,065,696 | Nasdaq | Wholesale-Motor Vehicles & Motor Vehicle Parts & Supplies | 54.7 | 0.4966 | 0.4739 | 0.5135 | 0.554 | 0.65 | null | [
"share count shrinking +4"
] | [
"debt not tagged in XBRL: estimated from non-current liabilities"
] | 19.715 | 4,976,028,088.055 | 10,122,028,088.055 | -0.6309 | -0.3508 | 53.41 | 34.58 | 17.42 | 0.1317 | 8.1843 | 10.1934 | 0.7905 | 0.1222 | 0.0981 | 0.1702 | 1.2651 | -3,203,000,000 | -0.6437 | -5,146,000,000 | -1.0342 | 1.7485 | 1.3482 | 847,000,000 | 3 | -0.0567 | -0.0124 | 0.032 | 0.0623 | 0.3568 | -0.0002 | CY2026Q3I | 2,025 | 14,782,000,000 | 5,284,000,000 | 3,022,000,000 | 319,000,000 | 6,295,000,000 | 5,274,000,000 | 5,465,000,000 | false | 8,487,000,000 | 252,398,077 | 267,556,377 | CY2023Q2I | 608,000,000 | 693,000,000 | 938,000,000 | 993,000,000 | 1,063,000,000 | 216,000,000 | 159,000,000 | 310,000,000 | -1,000,000 | 13,651,000,000 | 13,823,000,000 | 0 | 0 | 0 | 2026-02-19T00:00:00 | 0001065696-26-000012 | 10-K | https://www.sec.gov/Archives/edgar/data/1065696/000106569626000012/lkq-20251231.htm | null | ||||||
2026-11-02T00:00:00 | 28 | SHOE | SHOE STATION GROUP INC | 895,447 | Nasdaq | Retail-Shoe Stores | 54.5 | 0.5667 | 0.6348 | 0.3941 | 0.426 | 0.5 | null | [] | [
"debt not tagged in XBRL: estimated from non-current liabilities"
] | 14.78 | 401,296,332.24 | 627,954,332.24 | -0.6745 | -0.1506 | 45.41 | 21.28 | 12.58 | 0.1749 | 7.673 | 9.4064 | 0.5929 | 0.1303 | 0.1063 | 0.0662 | 1.6865 | 99,882,000 | 0.2489 | -226,658,000 | -0.5648 | 4.0416 | 0.7252 | 26,584,000 | 3 | -0.0067 | -0.0562 | 0 | 0.0417 | 0.0154 | 0 | CY2026Q2I | 2,025 | 1,167,621,000 | 590,710,000 | 146,158,000 | 118,012,000 | 676,793,000 | 18,018,000 | 344,670,000 | false | 490,828,000 | 27,151,308 | 27,335,595 | CY2023Q2I | 52,300,000 | 73,800,000 | 73,300,000 | 66,758,000 | 71,300,000 | 44,716,000 | 0 | 16,748,000 | 0 | 1,135,324,000 | 1,202,885,000 | 0 | 0 | 0 | 2026-03-26T00:00:00 | 0001193125-26-126279 | 10-K | https://www.sec.gov/Archives/edgar/data/895447/000119312526126279/scvl-20260131.htm | null | ||||||
2026-11-02T00:00:00 | 29 | INVE | INVE Technologies, Inc. | 1,036,044 | Nasdaq | Computer Peripheral Equipment, NEC | 54.3 | 0.4817 | 0.6536 | 0.5207 | 0.515 | 0.5 | null | [] | [
"earnings inconsistent"
] | 2.67 | 64,709,460.51 | -53,599,539.49 | -0.7033 | -0.2937 | 9 | 5.14 | 2.22 | 0.2027 | null | null | 0.4862 | -0.2782 | null | -0.1207 | 2.0566 | 124,697,000 | 1.927 | 118,309,000 | 1.8283 | 20.3471 | 0.0571 | -7,811,000 | 1 | 0.0478 | -0.1932 | null | null | null | null | CY2026Q2I | 2,025 | 140,682,000 | 132,297,000 | 6,502,000 | 119,407,000 | 133,082,000 | null | 1,098,000 | false | 7,600,000 | 24,235,753 | 23,129,816 | CY2023Q2I | -18,003,000 | 74,820,000 | -5,489,000 | -22,146,000 | -6,703,000 | 1,108,000 | null | null | null | 21,484,000 | 26,628,000 | 0 | 0 | 0 | 2026-03-26T00:00:00 | 0001193125-26-126351 | 10-K | https://www.sec.gov/Archives/edgar/data/1036044/000119312526126351/inve-20251231.htm | null | ||||||
2026-11-02T00:00:00 | 30 | BBW | BUILD-A-BEAR WORKSHOP INC | 1,113,809 | NYSE | Retail-Hobby, Toy & Game Shops | 51.4 | 0.3948 | 0.513 | 0.5584 | 0.541 | 0.5 | null | [
"share count shrinking +4"
] | [
"debt not tagged in XBRL: estimated from non-current liabilities",
"net income well above operating profit"
] | 29.611 | 371,246,224.673 | 455,746,224.673 | -0.5997 | -0.3982 | 73.98 | 70.62 | 23.79 | 0.2447 | 7.112 | null | 2.3349 | 0.1406 | null | 0.1064 | 0.4283 | -52,209,000 | -0.1406 | -84,500,000 | -0.2276 | 1.6044 | 1.1013 | 39,507,000 | 3 | -0.137 | 0.0673 | 0.0747 | null | null | null | CY2026Q2I | 2,025 | 334,101,000 | 122,895,000 | 76,600,000 | 14,004,000 | 158,997,000 | null | 98,504,000 | false | 175,104,000 | 12,537,443 | 14,527,013 | CY2023Q2I | 52,200,000 | 51,800,000 | 52,800,000 | null | 65,052,000 | 25,545,000 | 27,735,000 | null | null | 529,832,000 | 496,404,000 | 0 | 0 | 0 | 2026-04-16T00:00:00 | 0001437749-26-012501 | 10-K | https://www.sec.gov/Archives/edgar/data/1113809/000143774926012501/bbw20251218c_10k.htm | null | ||||||
2026-11-02T00:00:00 | 31 | SBC | SBC Medical Group Holdings Inc | 1,930,313 | Nasdaq | Services-Offices & Clinics of Doctors of Medicine | 50.1 | 0.4322 | 0.7826 | 0.2537 | 0.313 | 0.45 | null | [] | [] | 5.4 | 555,373,492.2 | 408,817,095.2 | -0.6429 | 0.6564 | 15.12 | 5.42 | 2.87 | 0.8815 | 10.8927 | 6.0578 | 2.105 | 0.0918 | 0.1651 | 0.0419 | 0.4751 | 132,643,644 | 0.2388 | 146,556,397 | 0.2639 | 3.306 | 0.4804 | 23,267,484 | 3 | null | -0.1548 | 0.009 | null | 0.0373 | null | CY2026Q2I | 2,025 | 406,659,022 | 259,387,524 | 78,459,956 | 184,311,213 | 263,836,341 | 15,179,809 | 37,754,816 | true | 126,743,880 | 102,846,943 | null | CY2023Q2I | 50,985,613 | 46,614,275 | 39,370,036 | 67,486,398 | 24,668,496 | 1,401,012 | 4,999,997 | null | null | 173,607,489 | 205,415,542 | 0 | 0 | 0 | 2026-03-27T00:00:00 | 0001193125-26-127557 | 10-K | https://www.sec.gov/Archives/edgar/data/1930313/000119312526127557/sbc-20251231.htm | null | ||||||
2026-11-02T00:00:00 | 32 | LE | LANDS' END, INC. | 799,288 | Nasdaq | Retail-Family Clothing Stores | 47.4 | 0.4611 | 0.529 | 0.4293 | 0.436 | 0.45 | null | [] | [] | 9.81 | 301,567,905.27 | 285,454,905.27 | -0.4815 | -0.3918 | 18.92 | 18.92 | 9.51 | 0.0315 | 54.7509 | 6.4488 | 0.6119 | 0.0183 | 0.1551 | 0.0676 | 1.6344 | -28,929,000 | -0.0959 | 16,113,000 | 0.0534 | 1.5792 | 0.9266 | 20,398,000 | 2 | -0.0419 | 0.0072 | null | null | null | null | CY2026Q2I | 2,025 | 949,566,000 | 427,767,000 | 270,871,000 | 16,113,000 | 492,870,000 | null | 0 | true | 456,696,000 | 30,740,867 | 32,086,612 | CY2023Q2I | 5,508,000 | 6,233,000 | -130,684,000 | 44,265,000 | 49,618,000 | 29,220,000 | null | null | null | 1,162,769,000 | 1,154,442,000 | 0 | 0 | 0 | 2026-03-26T00:00:00 | 0001193125-26-126210 | 10-K | https://www.sec.gov/Archives/edgar/data/799288/000119312526126210/le-20260130.htm | null | ||||||
2026-11-02T00:00:00 | 33 | UEIC | UNIVERSAL ELECTRONICS INC | 101,984 | Nasdaq | Household Audio & Video Equipment | 47.1 | 0.5978 | 0.4826 | 0.2353 | 0.29 | 0.417 | null | [] | [
"earnings inconsistent"
] | 5.018 | 64,657,241.116 | 41,374,241.116 | -0.6027 | 0.29 | 12.63 | 5.67 | 2.97 | 0.6896 | null | null | 0.4523 | -0.2877 | -0.1548 | 0.3055 | 2.2111 | 79,872,000 | 1.2353 | 23,283,000 | 0.3601 | 1.7721 | 0.8699 | 19,751,000 | 0 | -0.0018 | -0.0673 | 0.0477 | null | null | null | CY2026Q2I | 2,025 | 267,329,000 | 204,240,000 | 115,252,000 | 32,399,000 | 142,961,000 | null | 9,116,000 | false | 124,368,000 | 12,885,062 | 12,908,715 | CY2023Q2I | -18,599,000 | -24,029,000 | -98,238,000 | -6,404,000 | 23,626,000 | 3,875,000 | 3,086,000 | null | null | 368,288,000 | 394,879,000 | 0 | 0 | 0 | 2026-03-12T00:00:00 | 0000101984-26-000039 | 10-K | https://www.sec.gov/Archives/edgar/data/101984/000010198426000039/ueic-20251231.htm | null | ||||||
2026-11-02T00:00:00 | 34 | PPC | PILGRIMS PRIDE CORP | 802,481 | Nasdaq | Poultry Slaughtering and Processing | 46.1 | 0.5632 | 0.4696 | 0.2361 | 0.315 | 0.5 | null | [] | [] | 28.78 | 6,852,863,647.8 | 9,322,709,647.8 | -0.4731 | -0.2232 | 54.62 | 43.37 | 27.32 | 0.0534 | 6.3314 | 5.7778 | 1.7682 | 0.1579 | 0.1731 | 0.163 | 0.5655 | -2,582,204,000 | -0.3768 | -2,469,846,000 | -0.3604 | 1.5459 | 1.8187 | 1,116,750,000 | 3 | 0.0056 | 0.0346 | null | 0.291 | 0.1204 | null | CY2026Q3I | 2,025 | 10,936,423,000 | 4,466,339,000 | 2,889,209,000 | 935,771,000 | 3,875,618,000 | 1,316,811,000 | 3,405,617,000 | true | 7,048,543,000 | 238,112,010 | 236,789,929 | CY2023Q2I | 1,082,359,000 | 1,086,438,000 | 321,574,000 | 1,613,539,000 | 1,371,650,000 | 254,900,000 | null | 1,994,347,000 | null | 18,497,553,000 | 17,878,291,000 | 0 | 0 | 0 | 2026-02-12T00:00:00 | 0000802481-26-000011 | 10-K | https://www.sec.gov/Archives/edgar/data/802481/000080248126000011/ppc-20251228.htm | null | ||||||
2026-11-02T00:00:00 | 35 | KEQU | KEWAUNEE SCIENTIFIC CORP /DE/ | 55,529 | Nasdaq | Laboratory Apparatus & Furniture | 45.8 | 0.504 | 0.5609 | 0.205 | 0.294 | 0.5 | null | [] | [] | 34.715 | 99,646,283.15 | 110,233,283.15 | -0.4746 | -0.1695 | 66.07 | 42.55 | 32.79 | 0.0587 | 10.3604 | 6.5949 | 1.3285 | 0.0965 | 0.1516 | 0.1475 | 0.7527 | 5,371,000 | 0.0539 | -10,587,000 | -0.1062 | 2.2007 | 1.3143 | 14,696,000 | 3 | -0.0033 | 0.1727 | 0 | null | 0.071 | 0 | CY2026Q2I | 2,025 | 175,800,000 | 103,951,000 | 47,235,000 | 8,246,000 | 75,005,000 | 12,487,000 | 18,833,000 | true | 98,580,000 | 2,870,410 | 2,879,785 | CY2023Q2I | 9,618,000 | 11,405,000 | 18,753,000 | 16,715,000 | 18,633,000 | 3,937,000 | 0 | null | 0 | 281,999,000 | 240,472,000 | 0 | 0 | 0 | 2026-06-26T00:00:00 | 0000055529-26-000020 | 10-K | https://www.sec.gov/Archives/edgar/data/55529/000005552926000020/kequ-20260430.htm | null | ||||||
2026-11-02T00:00:00 | 36 | TGLS | Tecnoglass Holdings Inc. | 1,534,675 | NYSE | Flat Glass | 44.7 | 0.3101 | 0.5957 | 0.2825 | 0.348 | 0.5 | null | [
"share count shrinking +4"
] | [] | 40.57 | 1,799,872,471.12 | 1,944,452,471.12 | -0.5412 | -0.1842 | 88.42 | 53.73 | 34.74 | 0.1678 | 11.2798 | 8.427 | 2.2819 | 0.0887 | 0.1187 | 0.0192 | 0.4382 | 89,080,000 | 0.0495 | -144,580,000 | -0.0803 | 1.8596 | 0.8128 | 34,493,000 | 3 | -0.0694 | 0.105 | null | 0.0156 | 0.021 | 0.0038 | CY2026Q2I | 2,025 | 1,429,891,000 | 730,199,000 | 392,655,000 | 80,814,000 | 788,772,000 | 30,059,000 | 225,394,000 | true | 641,119,000 | 44,364,616 | 47,673,433 | CY2023Q2I | 159,566,000 | 161,309,000 | 182,882,000 | 230,741,000 | 135,755,000 | 101,262,000 | null | 28,127,000 | 6,841,000 | 983,610,000 | 890,181,000 | 0 | 0 | 1 | 2026-03-02T00:00:00 | 0001493152-26-008465 | 10-K | https://www.sec.gov/Archives/edgar/data/1534675/000149315226008465/form10-k.htm | null | ||||||
2026-11-02T00:00:00 | 37 | PSIX | POWER SOLUTIONS INTERNATIONAL, INC. | 1,137,091 | Nasdaq | Engines & Turbines | 44.5 | 0.3107 | 0.6348 | 0.3817 | 0.434 | 0.556 | null | [] | [] | 46.72 | 1,077,617,824 | 1,013,338,824 | -0.5752 | -0.2888 | 109.98 | 98.77 | 27.61 | 0.6921 | 9.4539 | 9.2362 | 5.3067 | 0.1058 | 0.1083 | 0.0224 | 0.1884 | 52,285,000 | 0.0485 | 64,279,000 | 0.0596 | 2.5729 | 1.2323 | 24,113,000 | 3 | 0.0042 | 0.5178 | null | null | 0.077 | null | CY2026Q2I | 2,025 | 453,317,000 | 302,534,000 | 117,585,000 | 70,062,000 | 203,068,000 | 34,921,000 | 5,783,000 | true | 250,249,000 | 23,065,450 | 22,968,522 | CY2023Q2I | 113,987,000 | 69,279,000 | 26,306,000 | 109,714,000 | 24,113,000 | null | null | null | null | 722,405,000 | 475,967,000 | 0 | 0 | 0 | 2026-03-02T00:00:00 | 0001628280-26-013207 | 10-K | https://www.sec.gov/Archives/edgar/data/1137091/000162828026013207/psix-20251231.htm | null | ||||||
2026-11-02T00:00:00 | 38 | QTTB | Q32 Bio Inc. | 1,661,998 | Nasdaq | Pharmaceutical Preparations | 43.8 | 0.3547 | 0.6014 | 0.43 | 0.451 | 0.5 | null | [
"share count shrinking +4"
] | [
"profits not backed by cash flow",
"earnings inconsistent",
"debt not tagged in XBRL: estimated from non-current liabilities"
] | 8.6 | 256,017,407.6 | 154,308,407.6 | -0.83 | 2.0605 | 50.59 | 15.97 | 2 | 3.3 | 8.5912 | 9.1296 | 2.4174 | 0.1164 | 0.1095 | -0.131 | 0.4137 | 99,684,000 | 0.3894 | 101,709,000 | 0.3973 | 20.3011 | 0.0941 | -33,543,000 | 1 | -0.4851 | null | null | null | null | null | CY2026Q2I | 2,025 | 115,867,000 | 109,646,000 | 5,401,000 | 106,270,000 | 105,905,000 | null | 4,561,000 | false | 9,962,000 | 29,769,466 | 57,811,083 | CY2023Q2I | 29,800,000 | -47,700,000 | -53,700,000 | 16,902,000 | -33,543,000 | 0 | null | null | null | 53,737,000 | 0 | 0 | 275,144.4 | 2 | 2026-03-10T00:00:00 | 0001193125-26-099339 | 10-K | https://www.sec.gov/Archives/edgar/data/1661998/000119312526099339/qttb-20251231.htm | null | ||||||
2026-11-02T00:00:00 | 39 | RXST | RxSight, Inc. | 1,111,485 | Nasdaq | Ophthalmic Goods | 42.2 | 0.3967 | 0.3478 | 0.9022 | 0.798 | 0.556 | null | [] | [
"dilution 17% in 3y",
"earnings inconsistent"
] | 4.845 | 201,519,325.32 | 197,083,325.32 | -0.9214 | -0.4829 | 61.68 | 12.63 | 4.51 | 0.0743 | null | null | 0.7652 | 0 | -0.2445 | -0.096 | 1.3068 | 238,036,000 | 1.1812 | 4,436,000 | 0.022 | 4.0699 | 0.3393 | -19,341,000 | 0 | 0.1669 | -0.0389 | null | null | null | null | CY2026Q2I | 2,025 | 352,700,000 | 327,396,000 | 80,444,000 | 13,352,000 | 263,340,000 | null | 8,916,000 | false | 89,360,000 | 41,593,256 | 35,643,669 | CY2023Q2I | -38.9 | -27.5 | -48.6 | -48,191,000 | -15,511,000 | 3,830,000 | null | null | null | 134,479,000 | 139,927,000 | 0 | 117,951.12 | 0 | 2026-02-25T00:00:00 | 0001193125-26-071775 | 10-K | https://www.sec.gov/Archives/edgar/data/1111485/000119312526071775/rxst-20251231.htm | null | ||||||
2026-11-02T00:00:00 | 40 | ASIX | AdvanSix Inc. | 1,673,985 | NYSE | Plastic Materials, Synth Resins & Nonvulcan Elastomers | 39.6 | 0.4296 | 0.4478 | 0.2112 | 0.298 | 0.5 | null | [] | [
"debt not tagged in XBRL: estimated from non-current liabilities",
"net income well above operating profit"
] | 15.448 | 417,114,321.328 | 954,262,321.328 | -0.5242 | 0.0044 | 32.47 | 25.37 | 14.72 | 0.0495 | 8.4607 | null | 0.5234 | 0.1182 | null | 0.0154 | 1.9105 | -451,243,000 | -1.0818 | -537,148,000 | -1.2878 | 1.2807 | 1.0994 | 6,418,000 | 3 | -0.0078 | null | 0.004 | 0.0412 | 0.0336 | null | CY2026Q2I | 2,025 | 1,673,016,000 | 424,861,000 | 331,739,000 | 7,217,000 | 796,912,000 | 56,192,000 | 544,365,000 | false | 876,104,000 | 27,001,186 | 27,213,058 | CY2023Q2I | 49,300,000 | 44,100,000 | 54,600,000 | null | 122,863,000 | 116,445,000 | 1,658,000 | 17,176,000 | null | null | null | 0 | 0 | 0 | 2026-02-20T00:00:00 | 0001673985-26-000008 | 10-K | https://www.sec.gov/Archives/edgar/data/1673985/000167398526000008/asix-20251231.htm | null | ||||||
2026-11-03T00:00:00 | 1 | KROS | Keros Therapeutics, Inc. | 1,664,710 | Nasdaq | Pharmaceutical Preparations | 81.1 | 0.776 | 0.8347 | 0.7441 | 0.701 | 0.6 | Early-stage biotech, milestones but high development risk | null | [
"share count shrinking +4"
] | [
"earnings inconsistent",
"debt not tagged in XBRL: estimated from non-current liabilities",
"P/E under 3: check for one-off gains",
"net income well above operating profit"
] | 10.985 | 217,801,660.18 | -26,677,339.82 | -0.8441 | -0.3636 | 70.48 | 21.69 | 10.06 | 0.0919 | 2.5031 | null | 0.8303 | 0.3995 | null | 0.4865 | 1.2044 | 241,603,000 | 1.1093 | 244,479,000 | 1.1225 | 21.9603 | 0.0964 | 105,954,000 | 1 | -0.3316 | null | 1.7217 | null | null | null | CY2026Q2I | 2,025 | 287,600,000 | 266,883,000 | 12,153,000 | 257,606,000 | 262,320,000 | null | 13,127,000 | false | 25,280,000 | 19,827,188 | 29,663,192 | CY2023Q2I | 87,014,000 | -187,353,000 | -152,992,000 | 67,569,000 | 107,505,000 | 1,551,000 | 375,000,000 | null | null | 243,864,000 | 0 | 0 | 0 | 1 | 2026-03-04T00:00:00 | 0001664710-26-000018 | 10-K | https://www.sec.gov/Archives/edgar/data/1664710/000166471026000018/kros-20251231.htm | WATCH | 45 | fortress | medium | Cash‑rich but still a pre‑revenue biotech; watch for trial readouts and dilution risk | |
2026-11-03T00:00:00 | 2 | SIGA | SIGA TECHNOLOGIES INC | 1,010,086 | Nasdaq | Pharmaceutical Preparations | 78.7 | 0.7209 | 0.972 | 0.77 | 0.689 | 0.5 | Pending FDA filing, modest revenue, regulatory uncertainty | null | [] | [
"revenue -32% y/y"
] | 3.051 | 219,213,483.516 | 104,229,884.516 | -0.71 | -0.6315 | 10.52 | 6.79 | 2.95 | 0.0342 | 9.4167 | 4.3975 | 1.3262 | 0.1062 | 0.2274 | 0.1983 | 0.754 | 159,931,631 | 0.7296 | 114,983,599 | 0.5245 | 21.7172 | 0.0632 | 43,471,453 | 3 | 0.0108 | -0.3182 | 0 | 0.1967 | 0.0051 | null | CY2026Q2I | 2,025 | 175,736,786 | 170,377,782 | 7,845,306 | 117,584,444 | 165,290,635 | 898,334 | 2,600,845 | false | 10,446,151 | 71,849,716 | 71,082,944 | CY2023Q2I | 23,279,143 | 59,214,216 | 68,068,826 | 23,702,156 | 43,471,453 | null | 0 | 43,116,529 | null | 94,574,902 | 138,719,350 | 0 | 0 | 0 | 2026-03-10T00:00:00 | 0001437749-26-007557 | 10-K | https://www.sec.gov/Archives/edgar/data/1010086/000143774926007557/siga20251231_10k.htm | WATCH | 55 | fortress | medium | Cash‑rich, single‑product govt play—big upside if contract rolls, but regulatory and renewal risk loom. | |
2026-11-03T00:00:00 | 3 | NUS | NU SKIN ENTERPRISES, INC. | 1,021,561 | NYSE | Wholesale-Drugs, Proprietaries & Druggists' Sundries | 68.5 | 0.7813 | 0.5133 | 0.7408 | 0.729 | 0.7 | Turnaround doubts, sales pressure, volatile earnings | null | [] | [
"P/E under 3: check for one-off gains"
] | 4.84 | 235,594,908.56 | 259,615,908.56 | -0.7508 | -0.4969 | 19.42 | 11.54 | 4.58 | 0.0568 | 1.4706 | 3.9478 | 0.4341 | 0.68 | 0.2533 | 0.1953 | 2.3037 | -70,642,000 | -0.2998 | -24,021,000 | -0.102 | 1.9823 | 1.0664 | 46,009,000 | 2 | -0.0257 | -0.1426 | 0.0851 | null | 0.0042 | 0 | CY2026Q2I | 2,025 | 1,121,530,000 | 508,149,000 | 256,347,000 | 189,643,000 | 542,739,000 | 4,750,000 | 213,664,000 | true | 578,791,000 | 48,676,634 | 49,958,985 | CY2023Q2I | 160,204,000 | -146,594,000 | 8,595,000 | 65,763,000 | 80,286,000 | 34,277,000 | 20,040,000 | null | 0 | 1,485,159,000 | 1,732,084,000 | 0 | 18,009.48 | 0 | 2026-02-13T00:00:00 | 0001140361-26-005130 | 10-K | https://www.sec.gov/Archives/edgar/data/1021561/000114036126005130/ef20060638_10k.htm | AVOID | 15 | stretched | high | Cheap price but fragile earnings, leverage and MLM risks outweigh cash cushion. | |
2026-11-03T00:00:00 | 4 | VITL | Vital Farms, Inc. | 1,579,733 | Nasdaq | Food and Kindred Products | 67.5 | 0.476 | 0.548 | 0.8859 | 0.845 | 0.75 | Q3 loss, revenue miss, heavy short interest | null | [
"insider buying +7"
] | [] | 9.92 | 425,925,219.2 | 459,608,219.2 | -0.8059 | -0.6917 | 51.12 | 34.3 | 8.4 | 0.181 | 6.4261 | 5.2008 | 1.5195 | 0.1556 | 0.1923 | -0.1132 | 0.6581 | -75,807,000 | -0.178 | -33,683,000 | -0.0791 | 1.5631 | 1.034 | -48,235,000 | 3 | 0.0412 | 0.2526 | null | null | 0.0068 | null | CY2026Q3I | 2,025 | 570,151,000 | 214,033,000 | 136,930,000 | 83,952,000 | 280,311,000 | 3,858,000 | 117,635,000 | true | 289,840,000 | 42,936,010 | 41,237,544 | CY2023Q2I | 66,280,000 | 53,390,000 | 25,570,000 | 88,373,000 | 33,715,000 | 81,950,000 | null | null | null | 759,444,000 | 606,307,000 | 199,187.04 | 0 | 11 | 2026-02-26T00:00:00 | 0001193125-26-073423 | 10-K | https://www.sec.gov/Archives/edgar/data/1579733/000119312526073423/vitl-20251228.htm | AVOID | 15 | solid | high | Premium egg brand looks cheap but faces structural headwinds and cash‑draining expansion. | |
2026-11-03T00:00:00 | 5 | CRTO | Criteo S.A. | 1,576,427 | Nasdaq | Services-Advertising Agencies | 66.4 | 0.7747 | 0.62 | 0.4827 | 0.428 | 0.3 | Strong shopper reach, stable ad tech business | null | [
"share count shrinking +4"
] | [] | 15.15 | 742,313,018.85 | 659,015,018.85 | -0.6927 | -0.2706 | 49.3 | 22.88 | 14.65 | 0.0341 | 4.982 | 3.2501 | 0.6584 | 0.2007 | 0.3077 | 0.2809 | 1.5189 | 26,419,000 | 0.0356 | 83,298,000 | 0.1122 | 1.2883 | 0.7509 | 208,498,000 | 3 | -0.1221 | 0.006 | 0.2049 | null | 0.2645 | 0 | CY2026Q2I | 2,025 | 2,010,784,000 | 873,072,000 | 677,715,000 | 252,236,000 | 1,127,515,000 | 531,794,000 | 168,938,000 | false | 846,653,000 | 48,997,559 | 55,812,266 | CY2023Q2I | 149,000,000 | 115,000,000 | 55,000,000 | 202,765,000 | 311,237,000 | 102,739,000 | 152,064,000 | null | 0 | 1,944,901,000 | 1,933,289,000 | 0 | 642,246.33 | 0 | 2026-02-26T00:00:00 | 0001576427-26-000014 | 10-K | https://www.sec.gov/Archives/edgar/data/1576427/000157642726000014/crto-20251231.htm | WATCH | 55 | solid | medium | Deeply discounted ad tech with cash moat, but flat growth and execution risk keep it cautious. | |
2026-11-03T00:00:00 | 6 | MED | MEDIFAST INC | 910,329 | NYSE | Miscellaneous Food Preparations & Kindred Products | 65.5 | 0.4102 | 0.7693 | 0.5104 | 0.588 | 0.77 | Deepening losses and declining sales pressure stock | null | [
"insider buying +8"
] | [
"revenue -36% y/y"
] | 12.69 | 141,907,155.93 | 101,145,155.93 | -0.8304 | 0.1151 | 74.81 | 12.69 | 9.62 | 0.3191 | null | null | 0.7872 | -0.1339 | -0.1405 | 0.0088 | 1.2704 | 142,449,000 | 1.0038 | 40,762,000 | 0.2872 | 4.8222 | 0.33 | 1,249,000 | 2 | 0.0269 | -0.3596 | 0 | 0.0014 | null | null | CY2026Q3I | 2,025 | 239,763,000 | 201,935,000 | 41,876,000 | 58,372,000 | 180,277,000 | null | 17,610,000 | false | 59,486,000 | 11,182,597 | 10,889,368 | CY2023Q2I | -19,000,000 | 2,000,000 | 99,000,000 | -14,213,000 | 6,863,000 | 5,614,000 | 0 | 195,000 | null | 385,788,000 | 602,463,000 | 1,554,779.1415 | 0 | 2 | 2026-02-17T00:00:00 | 0001628280-26-008656 | 10-K | https://www.sec.gov/Archives/edgar/data/910329/000162828026008656/med-20251231.htm | WATCH | 55 | fortress | medium | Cash‑rich but earnings volatile; transformation success critical for upside | |
2026-11-03T00:00:00 | 7 | IMXI | International Money Express, Inc. | 1,683,695 | Nasdaq | Services-Business Services, NEC | 64.8 | 0.5538 | 0.62 | 0.6127 | 0.669 | 0.8 | Regulatory review stalls deal, shares drop 8.5% | null | [
"share count shrinking +4"
] | [] | 8.385 | 253,324,492.395 | 216,502,492.395 | -0.6327 | -0.4447 | 22.83 | 15.94 | 8.385 | 0 | 7.7538 | 3.8904 | 1.4941 | 0.129 | 0.257 | 0.0624 | 0.6693 | 5,646,000 | 0.0223 | 36,822,000 | 0.1454 | 1.9594 | 1.652 | 15,813,000 | 3 | -0.147 | null | 0.0645 | null | 0.1201 | 0 | CY2026Q2I | 2,025 | 449,641,000 | 285,737,000 | 145,831,000 | 150,636,000 | 169,550,000 | 53,986,000 | 113,814,000 | true | 280,091,000 | 30,211,627 | 35,418,293 | CY2023Q2I | 32,671,000 | 58,821,000 | 59,515,000 | 55,650,000 | 36,887,000 | 21,074,000 | 16,334,000 | null | 0 | null | null | 0 | 0 | 0 | 2026-03-06T00:00:00 | 0001628280-26-015647 | 10-K | https://www.sec.gov/Archives/edgar/data/1683695/000162828026015647/imxi-20251231.htm | WATCH | 55 | solid | medium | Deep‑discounted remittance player with cash cushion but merger and regulatory headwinds | |
2026-11-03T00:00:00 | 8 | AMPY | Amplify Energy Corp. | 1,533,924 | NYSE | Crude Petroleum & Natural Gas | 64.3 | 0.7991 | 0.588 | 0.3264 | 0.288 | 0.2 | Small price rise, no major concerns | null | [
"insider buying +6"
] | [
"debt not tagged in XBRL: estimated from non-current liabilities"
] | 3.845 | 159,400,050.25 | 224,916,050.25 | -0.5064 | -0.2826 | 7.79 | 6.56 | 3.84 | 0.0013 | 3.6254 | 2.9233 | 0.363 | 0.2758 | 0.3421 | 0.3087 | 2.7546 | -71,298,000 | -0.4473 | -65,516,000 | -0.411 | 1.3069 | 0.312 | 49,200,000 | 3 | 0.0613 | -0.1063 | null | null | null | null | CY2026Q2I | 2,025 | 576,094,000 | 65,709,000 | 50,279,000 | 21,212,000 | 439,087,000 | null | 86,728,000 | false | 137,007,000 | 41,456,450 | 39,062,303 | CY2023Q2I | 43,968,000 | 12,946,000 | 392,750,000 | 76,940,000 | 49,200,000 | null | null | null | null | 263,361,000 | 294,681,000 | 98,750 | 0 | 1 | 2026-03-09T00:00:00 | 0001104659-26-025299 | 10-K | https://www.sec.gov/Archives/edgar/data/1533924/000110465926025299/ampy-20251231x10k.htm | AVOID | 15 | stretched | high | Deeply discounted but burdened by debt, shrinking reserves and high commodity risk. | |
2026-11-03T00:00:00 | 9 | SMPL | Simply Good Foods Co | 1,702,744 | Nasdaq | Food and Kindred Products | 64.1 | 0.5009 | 0.728 | 0.5664 | 0.606 | 0.7 | Sales fall, guidance lowered, fair value cut | null | [
"share count shrinking +4"
] | [] | 12.668 | 1,100,367,397.956 | 1,309,161,397.956 | -0.6964 | -0.3586 | 41.72 | 21.4 | 9.6 | 0.3196 | 10.6199 | 8.3446 | 0.7576 | 0.0942 | 0.1198 | 0.1435 | 1.3199 | -150,796,000 | -0.137 | -208,794,000 | -0.1897 | 5.5744 | 0.4023 | 157,915,000 | 3 | -0.1274 | 0.0898 | 0.0462 | null | 0.271 | 0.0016 | CY2026Q3I | 2,025 | 2,036,744,000 | 433,540,000 | 77,773,000 | 138,425,000 | 1,452,408,000 | 551,974,000 | 347,219,000 | true | 584,336,000 | 86,861,967 | 99,548,989 | CY2023Q2I | 103,614,000 | 139,309,000 | 133,575,000 | 156,887,000 | 178,457,000 | 20,542,000 | 50,886,000 | null | 1,713,000 | 1,450,920,000 | 1,331,321,000 | 0 | 0 | 1 | 2026-10-27T00:00:00 | 0001702744-26-000031 | 10-K | https://www.sec.gov/Archives/edgar/data/1702744/000170274426000031/atk-20260829.htm | WATCH | 45 | solid | medium | Cheap, cash‑rich snack maker but brand‑driven sales slump raises a medium‑risk flag. | |
2026-11-03T00:00:00 | 10 | USNA | USANA HEALTH SCIENCES INC | 896,264 | NYSE | Medicinal Chemicals & Botanical Products | 63.6 | 0.6302 | 0.84 | 0.5005 | 0.44 | 0.3 | Consistent earnings, quality seal, modest growth | null | [] | [] | 14.98 | 276,778,479.32 | 134,780,479.32 | -0.7205 | -0.2194 | 53.6 | 22.53 | 13.37 | 0.1204 | 25.7229 | 3.6007 | 0.5259 | 0.0389 | 0.2777 | 0.0308 | 1.9015 | 148,829,000 | 0.5377 | 141,998,000 | 0.513 | 2.6597 | 0.2513 | 8,526,000 | 3 | -0.0428 | 0.0828 | 0.0994 | null | 0.1552 | 0 | CY2026Q2I | 2,025 | 703,210,000 | 281,066,000 | 105,675,000 | 168,560,000 | 526,306,000 | 109,141,000 | 26,562,000 | false | 132,237,000 | 18,476,534 | 19,301,730 | CY2023Q2I | 10,760,000 | 42,030,000 | 63,788,000 | 37,432,000 | 22,349,000 | 13,823,000 | 27,507,000 | null | 0 | 925,257,000 | 854,503,000 | 0 | 426,891.595 | 0 | 2026-03-16T00:00:00 | 0000896264-26-000021 | 10-K | https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm | WATCH | 55 | fortress | medium | Cash‑rich, cheap but China‑centric direct‑selling risks keep it a cautious watch. | |
2026-11-03T00:00:00 | 11 | NAGE | Niagen Bioscience, Inc. | 1,386,570 | Nasdaq | Medicinal Chemicals & Botanical Products | 63.6 | 0.3916 | 0.7213 | 0.9072 | 0.875 | 0.8 | Sharp price drop, unclear growth prospects | null | [] | [
"debt not tagged in XBRL: estimated from non-current liabilities"
] | 2.315 | 183,176,694.63 | 192,187,694.63 | -0.8372 | -0.663 | 14.22 | 6.88 | 2.315 | 0 | 10.5383 | 11.8059 | 2.2196 | 0.0949 | 0.0847 | 0.0737 | 0.4505 | 73,725,000 | 0.4025 | -9,011,000 | -0.0492 | 6.4974 | 0.2915 | 13,504,000 | 2 | 0.0546 | 0.2995 | 0.0014 | null | null | null | CY2026Q2I | 2,025 | 106,589,000 | 97,786,000 | 15,050,000 | null | 82,528,000 | null | 9,011,000 | false | 24,061,000 | 79,126,002 | 75,032,367 | CY2023Q2I | 17,382,000 | 8,550,000 | -4,938,000 | 16,279,000 | 13,504,000 | null | 251,000 | null | null | 129,423,000 | 99,597,000 | 0 | 0 | 0 | 2026-03-04T00:00:00 | 0001386570-26-000013 | 10-K | https://www.sec.gov/Archives/edgar/data/1386570/000138657026000013/cdxc-20251231.htm | null | |||||
2026-11-03T00:00:00 | 12 | HDSN | HUDSON TECHNOLOGIES INC /NY | 925,528 | Nasdaq | Wholesale-Machinery, Equipment & Supplies | 63.6 | 0.5156 | 0.584 | 0.5879 | 0.652 | 0.8 | earnings miss, margins tighten, stock nosediving | null | [
"insider buying +8",
"share count shrinking +4"
] | [
"profits not backed by cash flow"
] | 4.335 | 182,453,851.245 | 168,144,851.245 | -0.7079 | -0.3616 | 14.84 | 7.48 | 4.23 | 0.0248 | 10.947 | 9.06 | 0.75 | 0.0913 | 0.1104 | -0.045 | 1.3333 | 139,354,000 | 0.7638 | 14,309,000 | 0.0784 | 3.2315 | 0.3239 | -8,214,000 | 3 | -0.0728 | null | 0.1097 | null | 0.2027 | null | CY2026Q2I | 2,025 | 322,063,000 | 218,153,000 | 67,508,000 | 25,600,000 | 243,264,000 | 65,282,000 | 11,291,000 | false | 78,799,000 | 42,088,547 | 45,395,085 | CY2023Q2I | 16,667,000 | 24,388,000 | 52,247,000 | 18,559,000 | -3,162,000 | 5,052,000 | 20,014,000 | null | null | null | 237,118,000 | 900,705.47 | 0 | 9 | 2026-03-16T00:00:00 | 0001104659-26-028445 | 10-K | https://www.sec.gov/Archives/edgar/data/925528/000110465926028445/hdsn-20251231x10k.htm | null | |||||
2026-11-03T00:00:00 | 13 | LULU | lululemon athletica inc. | 1,397,187 | Nasdaq | Apparel & Other Finishd Prods of Fabrics & Similar Matl | 62.9 | 0.4956 | 0.648 | 0.7205 | 0.654 | 0.5 | Near-term uncertainty, mixed analyst opinions | null | [
"share count shrinking +4"
] | [] | 107.14 | 11,618,042,712.98 | 11,618,042,712.98 | -0.7905 | -0.3723 | 511.29 | 210.81 | 94.46 | 0.1342 | 7.357 | 5.2556 | 2.4249 | 0.1359 | 0.1903 | 0.0793 | 0.4124 | 252,183,000 | 0.0217 | 0 | 0 | 2.19 | 0.7709 | 921,675,000 | 3 | -0.1108 | 0.0486 | 0.1014 | null | 0.0219 | 0 | CY2026Q2I | 2,025 | 8,484,578,000 | 3,945,587,000 | 1,801,651,000 | null | 4,791,174,000 | 185,840,000 | 0 | true | 3,693,404,000 | 108,437,957 | 121,949,471 | CY2023Q2I | 1,579,183,000 | 1,814,616,000 | 1,550,190,000 | 2,210,615,000 | 1,602,477,000 | 680,802,000 | 1,178,349,000 | null | 0 | 11,102,600,000 | 10,588,126,000 | 0 | 0 | 1 | 2026-03-17T00:00:00 | 0001397187-26-000020 | 10-K | https://www.sec.gov/Archives/edgar/data/1397187/000139718726000020/lulu-20260201.htm | null | |||||
2026-11-03T00:00:00 | 14 | PEW | GrabAGun Digital Holdings Inc. | 2,051,380 | NYSE | Retail-Miscellaneous Shopping Goods Stores | 62.7 | 0.452 | 0.6733 | 0.9043 | 0.813 | 0.6 | Gun sector regulatory risk, ownership change uncertainty | null | [] | [] | 2.165 | 63,896,593.27 | -25,950,406.73 | -0.8743 | -0.5293 | 17.22 | 4.34 | 1.84 | 0.1766 | null | null | 0.623 | -0.0392 | null | -0.1391 | 1.6052 | 89,135,000 | 1.395 | 89,847,000 | 1.4061 | 9.4247 | 0.1868 | -8,890,000 | 2 | null | 0.0357 | null | null | null | null | CY2026Q2I | 2,025 | 121,719,000 | 108,290,000 | 11,490,000 | 97,512,000 | 102,564,000 | null | 7,665,000 | true | 19,155,000 | 29,513,438 | null | CY2023Q2I | -2,507,000 | 4,509,000 | 4,519,000 | -4,364,000 | -417,000 | 8,473,000 | null | null | null | 96,449,000 | 93,122,000 | 0 | 0 | 0 | 2026-03-12T00:00:00 | 0001193125-26-104172 | 10-K | https://www.sec.gov/Archives/edgar/data/2051380/000119312526104172/pew-20251231.htm | null | |||||
2026-11-03T00:00:00 | 15 | BYRN | Byrna Technologies Inc. | 1,354,866 | Nasdaq | Miscellaneous Electrical Machinery, Equipment & Supplies | 62.7 | 0.4467 | 0.5773 | 0.9667 | 0.923 | 0.82 | Revenue miss and weak demand scare investors | null | [
"insider buying +6"
] | [
"profits not backed by cash flow"
] | 4.09 | 95,725,443.86 | 88,506,443.86 | -0.8767 | -0.7633 | 33.18 | 19.67 | 3.34 | 0.2246 | 9.8818 | 7.4765 | 1.7367 | 0.1012 | 0.1338 | -0.0961 | 0.5758 | 36,288,000 | 0.3791 | 7,219,000 | 0.0754 | 5.5356 | 0.1717 | -9,195,000 | 2 | 0.065 | 0.3774 | 0.0115 | null | 0.042 | null | CY2026Q3I | 2,025 | 64,583,000 | 45,752,000 | 8,265,000 | 8,418,000 | 55,119,000 | 2,714,000 | 1,199,000 | false | 9,464,000 | 23,404,754 | 21,977,027 | CY2023Q2I | 9,687,000 | 12,792,000 | -8,192,000 | 11,838,000 | -1,572,000 | 7,623,000 | 1,102,000 | null | null | 118,120,000 | 85,756,000 | 70,375 | 0 | 7 | 2026-02-05T00:00:00 | 0001437749-26-003206 | 10-K | https://www.sec.gov/Archives/edgar/data/1354866/000143774926003206/byrn20251130_10k.htm | null | |||||
2026-11-03T00:00:00 | 16 | YELP | YELP INC | 1,345,016 | NYSE | Services-Personal Services | 61.4 | 0.6013 | 0.62 | 0.443 | 0.49 | 0.6 | Mixed sentiment, analysts warn to avoid | null | [
"share count shrinking +4"
] | [
"debt not tagged in XBRL: estimated from non-current liabilities"
] | 19.71 | 1,069,535,969.91 | 1,153,584,969.91 | -0.593 | -0.3038 | 48.43 | 31.3 | 18.03 | 0.0932 | 7.3457 | 6.2518 | 1.6594 | 0.1361 | 0.16 | 0.3026 | 0.6026 | -52,537,000 | -0.0491 | -84,049,000 | -0.0786 | 1.7486 | 0.5369 | 323,676,000 | 3 | -0.2103 | 0.0375 | 0.272 | null | 0.3581 | 0 | CY2026Q2I | 2,025 | 990,565,000 | 293,501,000 | 167,847,000 | 94,142,000 | 644,527,000 | 354,708,000 | 178,191,000 | false | 346,038,000 | 54,263,621 | 68,713,576 | CY2023Q2I | 145,600,000 | 132,850,000 | 99,173,000 | 184,521,000 | 372,029,000 | 48,353,000 | 290,949,000 | null | 0 | 1,464,955,000 | 1,412,064,000 | 0 | 0 | 0 | 2026-02-27T00:00:00 | 0001345016-26-000019 | 10-K | https://www.sec.gov/Archives/edgar/data/1345016/000134501626000019/yelp-20251231.htm | null | |||||
2026-11-03T00:00:00 | 17 | MDXG | MIMEDX GROUP, INC. | 1,376,339 | Nasdaq | Surgical & Medical Instruments & Apparatus | 60.6 | 0.5667 | 0.84 | 0.7099 | 0.692 | 0.65 | Q3 earnings raise profit doubts, target cut | null | [] | [
"dilution 26% in 3y"
] | 3.195 | 466,232,263.245 | 345,441,263.245 | -0.6699 | -0.5671 | 9.68 | 7.22 | 3.195 | 0 | 9.5976 | 5.4071 | 2.2088 | 0.1042 | 0.1849 | 0.1587 | 0.4527 | 133,763,000 | 0.2869 | 120,791,000 | 0.2591 | 4.3511 | 0.2533 | 74,003,000 | 3 | 0.2568 | 0.1999 | 0 | null | 0.0735 | null | CY2026Q3I | 2,025 | 264,552,000 | 187,233,000 | 43,031,000 | 120,791,000 | 211,082,000 | 19,441,000 | 0 | true | 53,470,000 | 145,925,591 | 116,109,125 | CY2023Q2I | 48,578,000 | 42,419,000 | 58,228,000 | 63,887,000 | 74,003,000 | null | 0 | null | null | 418,630,000 | 348,879,000 | 0 | 0 | 0 | 2026-02-25T00:00:00 | 0001376339-26-000011 | 10-K | https://www.sec.gov/Archives/edgar/data/1376339/000137633926000011/mdxg-20251231.htm | null | |||||
2026-11-03T00:00:00 | 18 | LRN | Stride, Inc. | 1,157,408 | NYSE | Services-Educational Services | 60.5 | 0.4604 | 0.712 | 0.2086 | 0.359 | 0.71 | margin squeeze, downgrade shadow | null | [
"insider buying +10"
] | [] | 74.55 | 3,134,741,991.15 | 3,005,422,991.15 | -0.5486 | 0.163 | 165.17 | 100.01 | 62.68 | 0.1894 | 10.8868 | 8.3462 | 1.8751 | 0.0919 | 0.1198 | 0.1375 | 0.5333 | 895,216,000 | 0.2856 | 129,319,000 | 0.0413 | 2.559 | 0.5139 | 431,035,000 | 3 | -0.022 | 0.179 | null | null | 0.0975 | null | CY2026Q3I | 2,025 | 2,530,956,000 | 1,754,407,000 | 685,589,000 | 547,750,000 | 1,671,765,000 | 246,676,000 | 418,431,000 | true | 859,191,000 | 42,048,853 | 42,992,835 | CY2023Q2I | 287,941,000 | 204,183,000 | 126,867,000 | 360,094,000 | 432,816,000 | 1,781,000 | null | null | null | 2,405,317,000 | 2,040,069,000 | 12,240,309.84 | 0 | 1 | 2026-08-05T00:00:00 | 0001104659-26-090515 | 10-K | https://www.sec.gov/Archives/edgar/data/1157408/000110465926090515/lrn-20260630x10k.htm | null | |||||
2026-11-03T00:00:00 | 19 | CRMD | CorMedix Inc. | 1,410,098 | Nasdaq | Pharmaceutical Preparations | 60.1 | 0.7956 | 0.5147 | 0.6251 | 0.696 | 0.86 | Reimbursement drop and 52‑week low alarm market | null | [] | [
"dilution 42% in 3y",
"earnings inconsistent",
"debt not tagged in XBRL: estimated from non-current liabilities",
"P/E under 3: check for one-off gains"
] | 5.56 | 433,370,441.44 | 432,501,441.44 | -0.6251 | -0.5053 | 14.83 | 12.53 | 5.39 | 0.0315 | 2.6578 | 2.8806 | 0.9404 | 0.3762 | 0.3471 | 0.3987 | 1.0634 | 37,335,000 | 0.0862 | 869,000 | 0.002 | 2.5644 | 0.9618 | 172,786,000 | 1 | 0.4222 | 6.1703 | null | null | 0.0332 | 0.7119 | CY2026Q2I | 2,025 | 904,052,000 | 480,554,000 | 187,396,000 | 256,692,000 | 460,833,000 | 30,002,000 | 255,823,000 | false | 443,219,000 | 77,944,324 | 54,805,376 | CY2023Q2I | 163,055,000 | -17,930,000 | -46,339,000 | 150,141,000 | 175,046,000 | 2,260,000 | null | null | 308,511,000 | 311,709,000 | 43,472,000 | 0 | 0 | 0 | 2026-03-05T00:00:00 | 0001213900-26-023889 | 10-K | https://www.sec.gov/Archives/edgar/data/1410098/000121390026023889/ea0278169-10k_cormedix.htm | null | |||||
2026-11-03T00:00:00 | 20 | LFVN | Lifevantage Corp | 849,146 | Nasdaq | Pharmaceutical Preparations | 59.1 | 0.5316 | 0.584 | 0.4884 | 0.522 | 0.6 | Q3 EPS miss, shares slip | null | [
"insider buying +5"
] | [] | 5.862 | 73,435,313.976 | 81,730,313.976 | -0.7684 | -0.1145 | 25.31 | 9.97 | 4.15 | 0.4125 | 7.4896 | 6.6998 | 2.1863 | 0.1335 | 0.1493 | 0.1431 | 0.4574 | 9,775,000 | 0.1331 | -8,295,000 | -0.113 | 1.8934 | 0.8491 | 10,507,000 | 3 | null | 0.1417 | 0.0429 | 0.0281 | 0.0075 | null | CY2026Q2I | 2,025 | 62,111,000 | 38,297,000 | 20,227,000 | null | 33,589,000 | 465,000 | 8,295,000 | false | 28,522,000 | 12,527,348 | null | CY2023Q2I | 9,805,000 | 2,937,000 | 2,540,000 | 12,199,000 | 11,878,000 | 1,371,000 | 3,147,000 | 2,067,000 | null | 228,530,000 | 200,164,000 | 12,130.195 | 641 | 1 | 2026-08-27T00:00:00 | 0001193125-26-371257 | 10-K | https://www.sec.gov/Archives/edgar/data/849146/000119312526371257/lfvn-20260630.htm | null | |||||
2026-11-03T00:00:00 | 21 | UPWK | UPWORK, INC | 1,627,475 | Nasdaq | Services-Computer Processing & Data Preparation | 58.1 | 0.4698 | 0.748 | 0.4823 | 0.428 | 0.3 | Stock surging, price target raised, upbeat outlook | null | [
"share count shrinking +4"
] | [] | 10.12 | 1,272,864,646.68 | 1,044,878,646.68 | -0.5423 | -0.3859 | 22.11 | 22.11 | 8.05 | 0.2571 | 11.0276 | 8.0806 | 1.9462 | 0.0907 | 0.1238 | 0.1905 | 0.5138 | 290,832,000 | 0.2285 | 227,986,000 | 0.1791 | 2.251 | 0.4236 | 242,469,000 | 3 | -0.0675 | 0.024 | 0.1068 | null | 0.1602 | 0.0459 | CY2026Q3I | 2,025 | 931,097,000 | 567,904,000 | 252,287,000 | 227,986,000 | 654,025,000 | 149,192,000 | 0 | true | 277,072,000 | 125,777,139 | 134,883,597 | CY2023Q2I | 115,425,000 | 215,586,000 | 46,887,000 | 129,307,000 | 248,259,000 | 5,790,000 | 135,959,000 | null | 58,406,000 | 787,784,000 | 769,325,000 | 0 | 0 | 0 | 2026-02-13T00:00:00 | 0001627475-26-000012 | 10-K | https://www.sec.gov/Archives/edgar/data/1627475/000162747526000012/upwk-20251231.htm | null | |||||
2026-11-03T00:00:00 | 22 | EGAN | EGAIN Corp | 1,066,194 | Nasdaq | Services-Prepackaged Software | 57.3 | 0.4507 | 0.7 | 0.6021 | 0.607 | 0.62 | Governance shake‑up, limited positive news | null | [] | [
"net income well above operating profit"
] | 5.89 | 154,149,940.63 | 85,508,940.63 | -0.5921 | -0.5148 | 14.44 | 10.97 | 5.26 | 0.1198 | 4.7793 | 19.2892 | 1.8305 | 0.2092 | 0.0518 | 0.0305 | 0.5463 | 38,209,000 | 0.2479 | 68,641,000 | 0.4453 | 1.7261 | 0.7574 | 4,698,000 | 3 | null | -0.0471 | 0.1024 | null | 0.0891 | null | CY2026Q2I | 2,025 | 147,995,000 | 101,991,000 | 59,087,000 | 73,336,000 | 84,213,000 | 13,186,000 | 4,695,000 | false | 63,782,000 | 26,171,467 | null | CY2023Q2I | 32,254,000 | 7,780,000 | 2,109,000 | 4,433,000 | 5,263,000 | 565,000 | 15,781,000 | null | null | 88,431,000 | 92,803,000 | 0 | 0 | 0 | 2026-09-10T00:00:00 | 0001104659-26-106739 | 10-K | https://www.sec.gov/Archives/edgar/data/1066194/000110465926106739/egan-20260630x10k.htm | null | |||||
2026-11-03T00:00:00 | 23 | SHOE | SHOE STATION GROUP INC | 895,447 | Nasdaq | Retail-Shoe Stores | 57.1 | 0.5947 | 0.644 | 0.446 | 0.465 | 0.51 | Inventory concerns amid mixed retail sentiment | null | [] | [
"debt not tagged in XBRL: estimated from non-current liabilities"
] | 14.26 | 387,177,652.08 | 613,835,652.08 | -0.686 | -0.1781 | 45.41 | 21.28 | 12.58 | 0.1335 | 7.403 | 9.1949 | 0.5721 | 0.1351 | 0.1088 | 0.0687 | 1.748 | 99,882,000 | 0.258 | -226,658,000 | -0.5854 | 4.0416 | 0.7252 | 26,584,000 | 3 | -0.0067 | -0.0562 | 0 | 0.0433 | 0.0154 | 0 | CY2026Q2I | 2,025 | 1,167,621,000 | 590,710,000 | 146,158,000 | 118,012,000 | 676,793,000 | 18,018,000 | 344,670,000 | false | 490,828,000 | 27,151,308 | 27,335,595 | CY2023Q2I | 52,300,000 | 73,800,000 | 73,300,000 | 66,758,000 | 71,300,000 | 44,716,000 | 0 | 16,748,000 | 0 | 1,135,324,000 | 1,202,885,000 | 0 | 0 | 0 | 2026-03-26T00:00:00 | 0001193125-26-126279 | 10-K | https://www.sec.gov/Archives/edgar/data/895447/000119312526126279/scvl-20260131.htm | null | |||||
2026-11-03T00:00:00 | 24 | LKQ | LKQ CORP | 1,065,696 | Nasdaq | Wholesale-Motor Vehicles & Motor Vehicle Parts & Supplies | 56.6 | 0.5049 | 0.476 | 0.5599 | 0.605 | 0.71 | Q3 tumble and CEO exit worry investors | null | [
"share count shrinking +4"
] | [
"debt not tagged in XBRL: estimated from non-current liabilities"
] | 19.235 | 4,854,877,011.095 | 10,000,877,011.095 | -0.6399 | -0.3704 | 53.41 | 34.58 | 17.42 | 0.1042 | 7.985 | 10.0714 | 0.7712 | 0.1252 | 0.0993 | 0.1745 | 1.2966 | -3,203,000,000 | -0.6597 | -5,146,000,000 | -1.06 | 1.7485 | 1.3482 | 847,000,000 | 3 | -0.0567 | -0.0124 | 0.0328 | 0.0639 | 0.3568 | -0.0002 | CY2026Q3I | 2,025 | 14,782,000,000 | 5,284,000,000 | 3,022,000,000 | 319,000,000 | 6,295,000,000 | 5,274,000,000 | 5,465,000,000 | false | 8,487,000,000 | 252,398,077 | 267,556,377 | CY2023Q2I | 608,000,000 | 693,000,000 | 938,000,000 | 993,000,000 | 1,063,000,000 | 216,000,000 | 159,000,000 | 310,000,000 | -1,000,000 | 13,651,000,000 | 13,823,000,000 | 0 | 0 | 0 | 2026-02-19T00:00:00 | 0001065696-26-000012 | 10-K | https://www.sec.gov/Archives/edgar/data/1065696/000106569626000012/lkq-20251231.htm | null | |||||
2026-11-03T00:00:00 | 25 | SPRO | Spero Therapeutics, Inc. | 1,701,108 | Nasdaq | Pharmaceutical Preparations | 56.1 | 0.612 | 0.6413 | 0.704 | 0.613 | 0.4 | Limited news, executive changes only | null | [] | [
"profits not backed by cash flow"
] | 1.045 | 60,855,394.215 | 10,215,394.215 | -0.654 | -0.5752 | 3.02 | 2.85 | 1.04 | 0.0048 | 7.0993 | 1.6179 | 1.3767 | 0.1409 | 0.6181 | -0.2074 | 0.7264 | 43,022,000 | 0.707 | 50,640,000 | 0.8321 | 6.1206 | 0.1937 | -12,624,000 | 2 | 0.1051 | 0.3924 | null | null | null | null | CY2026Q2I | 2,025 | 52,766,000 | 51,584,000 | 8,428,000 | 50,774,000 | 44,204,000 | null | 134,000 | false | 8,562,000 | 58,234,827 | 52,696,289 | CY2023Q2I | 8,572,000 | -68,566,000 | 22,806,000 | 6,314,000 | -12,624,000 | null | null | null | null | 66,802,000 | 47,977,000 | 0 | 0 | 0 | 2026-03-26T00:00:00 | 0001193125-26-126192 | 10-K | https://www.sec.gov/Archives/edgar/data/1701108/000119312526126192/spro-20251231.htm | null | |||||
2026-11-03T00:00:00 | 26 | SMID | SMITH MIDLAND CORP | 924,719 | Nasdaq | Concrete Products, Except Block & Brick | 55.6 | 0.3942 | 0.728 | 0.4237 | 0.447 | 0.5 | little specific news, sector focus | null | [
"insider buying +5"
] | [] | 23.875 | 126,693,976.75 | 130,168,976.75 | -0.5137 | -0.3701 | 49.1 | 38.41 | 21.29 | 0.1214 | 10.1307 | 7.6597 | 2.2212 | 0.0987 | 0.1306 | 0.0392 | 0.4502 | 16,430,000 | 0.1297 | -3,475,000 | -0.0274 | 4.0603 | 0.5199 | 4,963,000 | 3 | null | 0.1903 | null | null | null | null | CY2026Q2I | 2,025 | 86,693,000 | 46,084,000 | 11,350,000 | null | 57,039,000 | null | 3,475,000 | true | 29,654,000 | 5,306,554 | null | CY2023Q2I | 12,506,000 | 7,675,000 | 795,000 | 16,994,000 | 14,301,000 | 9,338,000 | null | null | null | 93,446,000 | 78,508,000 | 9,804.75 | 0 | 1 | 2026-04-14T00:00:00 | 0001654954-26-003505 | 10-K | https://www.sec.gov/Archives/edgar/data/924719/000165495426003505/smid_10k.htm | null | |||||
2026-11-03T00:00:00 | 27 | CUVL | Clinuvel Pharmaceuticals Ltd | 1,290,877 | Nasdaq | American Depositary Receipts | 55.4 | 0.4862 | 0.8133 | 0.4299 | 0.385 | 0.28 | New drug filing boosts outlook | null | [] | [] | 5.075 | 255,921,582.35 | 244,017,790.35 | -0.5699 | -0.3142 | 11.8 | 8.75 | 4.91 | 0.0336 | 11.0679 | 9.2013 | 1.3568 | 0.0904 | 0.1087 | 0.1059 | 0.737 | 181,163,684 | 0.7079 | 11,903,792 | 0.0465 | 14.7186 | 0.0815 | 27,104,961 | 2 | null | 0.0554 | 0.0007 | 0.0066 | null | null | CY2026Q2I | 2,025 | 203,983,448 | 196,527,135 | 13,352,290 | 13,914,953 | 188,619,997 | null | 2,011,161 | false | 15,363,451 | 50,427,898 | null | CY2023Q2I | 23,122,864 | 23,346,174 | null | 26,520,057 | 27,295,554 | 190,593 | 173,965 | 1,693,879 | null | 61,120,888 | 57,911,843 | 0 | 0 | 0 | 2026-10-30T00:00:00 | 0001493152-26-049364 | 20-F | https://www.sec.gov/Archives/edgar/data/1290877/000149315226049364/form20-f.htm | null | |||||
2026-11-03T00:00:00 | 28 | INVE | INVE Technologies, Inc. | 1,036,044 | Nasdaq | Computer Peripheral Equipment, NEC | 55.1 | 0.48 | 0.6547 | 0.545 | 0.541 | 0.53 | Buyback rally offsets loss forecast | null | [] | [
"earnings inconsistent"
] | 2.655 | 64,345,924.215 | -53,963,075.785 | -0.705 | -0.292 | 9 | 5.14 | 2.22 | 0.1959 | null | null | 0.4835 | -0.2798 | null | -0.1214 | 2.0682 | 124,697,000 | 1.9379 | 118,309,000 | 1.8386 | 20.3471 | 0.0571 | -7,811,000 | 1 | 0.0478 | -0.1932 | null | null | null | null | CY2026Q2I | 2,025 | 140,682,000 | 132,297,000 | 6,502,000 | 119,407,000 | 133,082,000 | null | 1,098,000 | false | 7,600,000 | 24,235,753 | 23,129,816 | CY2023Q2I | -18,003,000 | 74,820,000 | -5,489,000 | -22,146,000 | -6,703,000 | 1,108,000 | null | null | null | 21,484,000 | 26,628,000 | 0 | 0 | 0 | 2026-03-26T00:00:00 | 0001193125-26-126351 | 10-K | https://www.sec.gov/Archives/edgar/data/1036044/000119312526126351/inve-20251231.htm | null | |||||
2026-11-03T00:00:00 | 29 | PLAB | PHOTRONICS INC | 810,136 | Nasdaq | Semiconductors & Related Devices | 55.1 | 0.5191 | 0.872 | 0.112 | 0.138 | 0.2 | cheap valuation, strong upside potential | null | [
"share count shrinking +4"
] | [] | 28.32 | 1,669,851,927.36 | 1,124,231,927.36 | -0.472 | 0.3409 | 53.64 | 53.64 | 21.06 | 0.3447 | 12.2419 | 5.4008 | 1.3039 | 0.0817 | 0.1852 | 0.0357 | 0.767 | 727,815,000 | 0.4359 | 545,620,000 | 0.3267 | 4.9414 | 0.1929 | 59,661,000 | 3 | -0.0569 | -0.0204 | 0.0583 | null | null | null | CY2026Q2I | 2,025 | 1,990,743,000 | 974,856,000 | 197,283,000 | 549,513,000 | 1,280,694,000 | null | 3,893,000 | true | 247,041,000 | 58,963,698 | 62,518,181 | CY2023Q2I | 136,405,000 | 130,688,000 | 125,485,000 | 208,161,000 | 247,798,000 | 188,137,000 | 97,422,000 | null | null | 849,294,000 | 866,946,000 | 0 | 806,765 | 0 | 2025-12-17T00:00:00 | 0001140361-25-045801 | 10-K | https://www.sec.gov/Archives/edgar/data/810136/000114036125045801/ef20057458_10k.htm | null | |||||
2026-11-03T00:00:00 | 30 | CALM | CAL-MAINE FOODS INC | 16,160 | Nasdaq | Agricultural Prod-Livestock & Animal Specialties | 55 | 0.5431 | 0.824 | 0.2358 | 0.285 | 0.4 | egg price dip offsets upgrade optimism | null | [] | [
"debt not tagged in XBRL: estimated from non-current liabilities",
"revenue -32% y/y"
] | 65.47 | 3,058,143,833.11 | 3,186,906,833.11 | -0.4358 | -0.2763 | 116.04 | 90.32 | 62.6 | 0.0458 | 9.6568 | 9.1006 | 1.1901 | 0.1036 | 0.1099 | 0.1074 | 0.8403 | 1,038,461,000 | 0.3396 | -128,763,000 | -0.0421 | 7.7011 | 0.1687 | 328,533,000 | 3 | null | -0.3168 | null | 0.0757 | 0.0322 | 0.1399 | CY2026Q3I | 2,025 | 3,013,379,000 | 1,471,893,000 | 191,127,000 | 113,542,000 | 2,569,736,000 | 97,059,000 | 242,305,000 | false | 433,432,000 | 46,710,613 | null | CY2023Q2I | 316,682,000 | 1,220,048,000 | 277,888,000 | 350,186,000 | 479,753,000 | 151,220,000 | null | 231,622,000 | 427,794,000 | 2,911,632,000 | 4,261,885,000 | 0 | 0 | 0 | 2026-07-22T00:00:00 | 0001562762-26-000080 | 10-K | https://www.sec.gov/Archives/edgar/data/16160/000156276226000080/calm2026053010K.htm | null | |||||
2026-11-03T00:00:00 | 31 | ETD | ETHAN ALLEN INTERIORS INC | 896,156 | NYSE | Wood Household Furniture, (No Upholstered) | 54.8 | 0.5 | 0.656 | 0.1199 | 0.336 | 0.84 | board fight, activist pressure | null | [
"insider buying +5"
] | [
"debt not tagged in XBRL: estimated from non-current liabilities"
] | 20.4 | 514,131,061.2 | 540,351,061.2 | -0.4099 | -0.0933 | 34.57 | 25.03 | 18.84 | 0.0828 | 9.9646 | 8.717 | 1.0903 | 0.1004 | 0.1147 | 0.0981 | 0.9172 | 57,241,000 | 0.1113 | -26,220,000 | -0.051 | 2.0588 | 0.5264 | 50,428,000 | 3 | null | -0.0489 | 0 | 0.0974 | 0.0353 | null | CY2026Q2I | 2,025 | 719,673,000 | 305,453,000 | 148,364,000 | 73,628,000 | 471,546,000 | 25,388,000 | 99,848,000 | false | 248,212,000 | 25,202,503 | null | CY2023Q2I | 51,596,000 | 63,816,000 | 105,807,000 | 61,988,000 | 61,696,000 | 11,268,000 | 0 | 50,084,000 | null | 614,649,000 | 646,221,000 | 24,610 | 597,804.96 | 1 | 2026-09-03T00:00:00 | 0001437749-26-029578 | 10-K | https://www.sec.gov/Archives/edgar/data/896156/000143774926029578/eth20260630c_10k.htm | null | |||||
2026-11-03T00:00:00 | 32 | LE | LANDS' END, INC. | 799,288 | Nasdaq | Retail-Family Clothing Stores | 51.9 | 0.4809 | 0.5413 | 0.45 | 0.549 | 0.78 | stock declines, risks from Anthropic listing | null | [] | [] | 9.65 | 296,649,366.55 | 280,536,366.55 | -0.49 | -0.4123 | 18.92 | 18.92 | 9.51 | 0.0147 | 53.8579 | 6.3377 | 0.6019 | 0.0186 | 0.1578 | 0.0688 | 1.6615 | -28,929,000 | -0.0975 | 16,113,000 | 0.0543 | 1.5792 | 0.9266 | 20,398,000 | 2 | -0.0419 | 0.0072 | null | null | null | null | CY2026Q2I | 2,025 | 949,566,000 | 427,767,000 | 270,871,000 | 16,113,000 | 492,870,000 | null | 0 | true | 456,696,000 | 30,740,867 | 32,086,612 | CY2023Q2I | 5,508,000 | 6,233,000 | -130,684,000 | 44,265,000 | 49,618,000 | 29,220,000 | null | null | null | 1,162,769,000 | 1,154,442,000 | 0 | 0 | 0 | 2026-03-26T00:00:00 | 0001193125-26-126210 | 10-K | https://www.sec.gov/Archives/edgar/data/799288/000119312526126210/le-20260130.htm | null | |||||
2026-11-03T00:00:00 | 33 | SBC | SBC Medical Group Holdings Inc | 1,930,313 | Nasdaq | Services-Offices & Clinics of Doctors of Medicine | 51.4 | 0.4578 | 0.796 | 0.2648 | 0.305 | 0.4 | AI partnership boost, mixed coverage | null | [] | [] | 5.22 | 536,861,042.46 | 390,304,645.46 | -0.6548 | 0.6571 | 15.12 | 5.42 | 2.87 | 0.8188 | 10.5297 | 5.7835 | 2.0348 | 0.095 | 0.1729 | 0.0433 | 0.4914 | 132,643,644 | 0.2471 | 146,556,397 | 0.273 | 3.306 | 0.4804 | 23,267,484 | 3 | null | -0.1548 | 0.0093 | null | 0.0373 | null | CY2026Q2I | 2,025 | 406,659,022 | 259,387,524 | 78,459,956 | 184,311,213 | 263,836,341 | 15,179,809 | 37,754,816 | true | 126,743,880 | 102,846,943 | null | CY2023Q2I | 50,985,613 | 46,614,275 | 39,370,036 | 67,486,398 | 24,668,496 | 1,401,012 | 4,999,997 | null | null | 173,607,489 | 205,415,542 | 0 | 0 | 0 | 2026-03-27T00:00:00 | 0001193125-26-127557 | 10-K | https://www.sec.gov/Archives/edgar/data/1930313/000119312526127557/sbc-20251231.htm | null | |||||
2026-11-03T00:00:00 | 34 | BBW | BUILD-A-BEAR WORKSHOP INC | 1,113,809 | NYSE | Retail-Hobby, Toy & Game Shops | 50.4 | 0.412 | 0.52 | 0.5511 | 0.476 | 0.3 | Michael Burry bullish, upgraded to Hold | null | [
"share count shrinking +4"
] | [
"debt not tagged in XBRL: estimated from non-current liabilities",
"net income well above operating profit"
] | 29.51 | 369,979,942.93 | 454,479,942.93 | -0.6011 | -0.394 | 73.98 | 70.62 | 23.79 | 0.2404 | 7.0877 | null | 2.327 | 0.1411 | null | 0.1068 | 0.4297 | -52,209,000 | -0.1411 | -84,500,000 | -0.2284 | 1.6044 | 1.1013 | 39,507,000 | 3 | -0.137 | 0.0673 | 0.075 | null | null | null | CY2026Q2I | 2,025 | 334,101,000 | 122,895,000 | 76,600,000 | 14,004,000 | 158,997,000 | null | 98,504,000 | false | 175,104,000 | 12,537,443 | 14,527,013 | CY2023Q2I | 52,200,000 | 51,800,000 | 52,800,000 | null | 65,052,000 | 25,545,000 | 27,735,000 | null | null | 529,832,000 | 496,404,000 | 0 | 0 | 0 | 2026-04-16T00:00:00 | 0001437749-26-012501 | 10-K | https://www.sec.gov/Archives/edgar/data/1113809/000143774926012501/bbw20251218c_10k.htm | null | |||||
2026-11-03T00:00:00 | 35 | JBI | Janus International Group, Inc. | 1,839,839 | NYSE | Metal Doors, Sash, Frames, Moldings & Trim | 50.4 | 0.384 | 0.56 | 0.4639 | 0.475 | 0.5 | upcoming results, modest price movement | null | [
"share count shrinking +4"
] | [] | 4.72 | 643,976,928.8 | 1,188,976,928.8 | -0.6939 | -0.2027 | 15.42 | 7.27 | 4.18 | 0.1292 | 11.9698 | 10.6635 | 1.1258 | 0.0835 | 0.0938 | 0.177 | 0.8882 | -366,900,000 | -0.5697 | -545,000,000 | -0.8463 | 2.9392 | 1.292 | 114,000,000 | 3 | -0.0708 | -0.0826 | 0.0247 | null | 0.3266 | 0.0002 | CY2026Q2I | 2,025 | 1,311,000,000 | 372,100,000 | 126,600,000 | null | 572,000,000 | 428,200,000 | 545,000,000 | true | 739,000,000 | 136,435,790 | 146,827,066 | CY2023Q2I | 53,800,000 | 70,400,000 | 135,700,000 | 111,500,000 | 139,500,000 | 25,500,000 | 15,900,000 | null | 100,000 | 884,200,000 | 963,800,000 | 0 | 0 | 0 | 2026-03-04T00:00:00 | 0001839839-26-000006 | 10-K | https://www.sec.gov/Archives/edgar/data/1839839/000183983926000006/jbi-20260103.htm | null | |||||
2026-11-03T00:00:00 | 36 | PPC | PILGRIMS PRIDE CORP | 802,481 | Nasdaq | Poultry Slaughtering and Processing | 48.7 | 0.5742 | 0.472 | 0.3163 | 0.386 | 0.55 | tariff scrutiny, mixed earnings | null | [] | [] | 26.965 | 6,420,690,349.65 | 8,890,536,349.65 | -0.5063 | -0.2813 | 54.62 | 43.37 | 26.965 | 0 | 5.9321 | 5.51 | 1.6567 | 0.1686 | 0.1815 | 0.1739 | 0.6036 | -2,582,204,000 | -0.4022 | -2,469,846,000 | -0.3847 | 1.5459 | 1.8187 | 1,116,750,000 | 3 | 0.0056 | 0.0346 | null | 0.3106 | 0.1204 | null | CY2026Q3I | 2,025 | 10,936,423,000 | 4,466,339,000 | 2,889,209,000 | 935,771,000 | 3,875,618,000 | 1,316,811,000 | 3,405,617,000 | true | 7,048,543,000 | 238,112,010 | 236,789,929 | CY2023Q2I | 1,082,359,000 | 1,086,438,000 | 321,574,000 | 1,613,539,000 | 1,371,650,000 | 254,900,000 | null | 1,994,347,000 | null | 18,497,553,000 | 17,878,291,000 | 0 | 0 | 0 | 2026-02-12T00:00:00 | 0000802481-26-000011 | 10-K | https://www.sec.gov/Archives/edgar/data/802481/000080248126000011/ppc-20251228.htm | null | |||||
2026-11-03T00:00:00 | 37 | UEIC | UNIVERSAL ELECTRONICS INC | 101,984 | Nasdaq | Household Audio & Video Equipment | 46.9 | 0.5898 | 0.484 | 0.2143 | 0.294 | 0.48 | mixed momentum, modest earnings forecast | null | [] | [
"earnings inconsistent"
] | 5.25 | 67,646,575.5 | 44,363,575.5 | -0.5843 | 0.4665 | 12.63 | 5.67 | 2.97 | 0.7677 | null | null | 0.4732 | -0.2749 | -0.1444 | 0.292 | 2.1134 | 79,872,000 | 1.1807 | 23,283,000 | 0.3442 | 1.7721 | 0.8699 | 19,751,000 | 0 | -0.0018 | -0.0673 | 0.0456 | null | null | null | CY2026Q2I | 2,025 | 267,329,000 | 204,240,000 | 115,252,000 | 32,399,000 | 142,961,000 | null | 9,116,000 | false | 124,368,000 | 12,885,062 | 12,908,715 | CY2023Q2I | -18,599,000 | -24,029,000 | -98,238,000 | -6,404,000 | 23,626,000 | 3,875,000 | 3,086,000 | null | null | 368,288,000 | 394,879,000 | 0 | 0 | 0 | 2026-03-12T00:00:00 | 0000101984-26-000039 | 10-K | https://www.sec.gov/Archives/edgar/data/101984/000010198426000039/ueic-20251231.htm | null | |||||
2026-11-03T00:00:00 | 38 | KEQU | KEWAUNEE SCIENTIFIC CORP /DE/ | 55,529 | Nasdaq | Laboratory Apparatus & Furniture | 46.7 | 0.5404 | 0.564 | 0.2407 | 0.273 | 0.35 | little news, modest price gains | null | [] | [] | 33.65 | 96,589,296.5 | 107,176,296.5 | -0.4907 | -0.1675 | 66.07 | 42.55 | 32.79 | 0.0262 | 10.0426 | 6.412 | 1.2878 | 0.0996 | 0.156 | 0.1521 | 0.7765 | 5,371,000 | 0.0556 | -10,587,000 | -0.1096 | 2.2007 | 1.3143 | 14,696,000 | 3 | -0.0033 | 0.1727 | 0 | null | 0.071 | 0 | CY2026Q2I | 2,025 | 175,800,000 | 103,951,000 | 47,235,000 | 8,246,000 | 75,005,000 | 12,487,000 | 18,833,000 | true | 98,580,000 | 2,870,410 | 2,879,785 | CY2023Q2I | 9,618,000 | 11,405,000 | 18,753,000 | 16,715,000 | 18,633,000 | 3,937,000 | 0 | null | 0 | 281,999,000 | 240,472,000 | 0 | 0 | 0 | 2026-06-26T00:00:00 | 0000055529-26-000020 | 10-K | https://www.sec.gov/Archives/edgar/data/55529/000005552926000020/kequ-20260430.htm | null | |||||
2026-11-03T00:00:00 | 39 | TGLS | Tecnoglass Holdings Inc. | 1,534,675 | NYSE | Flat Glass | 45.9 | 0.3173 | 0.596 | 0.2823 | 0.378 | 0.6 | low price, earnings uncertainty | null | [
"share count shrinking +4"
] | [] | 39.59 | 1,756,395,147.44 | 1,900,975,147.44 | -0.5523 | -0.119 | 88.42 | 53.73 | 34.74 | 0.1396 | 11.0073 | 8.2386 | 2.2267 | 0.0908 | 0.1214 | 0.0196 | 0.4491 | 89,080,000 | 0.0507 | -144,580,000 | -0.0823 | 1.8596 | 0.8128 | 34,493,000 | 3 | -0.0694 | 0.105 | null | 0.016 | 0.021 | 0.0039 | CY2026Q2I | 2,025 | 1,429,891,000 | 730,199,000 | 392,655,000 | 80,814,000 | 788,772,000 | 30,059,000 | 225,394,000 | true | 641,119,000 | 44,364,616 | 47,673,433 | CY2023Q2I | 159,566,000 | 161,309,000 | 182,882,000 | 230,741,000 | 135,755,000 | 101,262,000 | null | 28,127,000 | 6,841,000 | 983,610,000 | 890,181,000 | 0 | 0 | 1 | 2026-03-02T00:00:00 | 0001493152-26-008465 | 10-K | https://www.sec.gov/Archives/edgar/data/1534675/000149315226008465/form10-k.htm | null | |||||
2026-11-03T00:00:00 | 40 | RXST | RxSight, Inc. | 1,111,485 | Nasdaq | Ophthalmic Goods | 44.5 | 0.4129 | 0.368 | 0.92 | 0.83 | 0.62 | stake reductions, limited news | null | [] | [
"dilution 17% in 3y",
"earnings inconsistent"
] | 4.705 | 195,696,269.48 | 191,260,269.48 | -0.9237 | -0.5164 | 61.68 | 12.63 | 4.51 | 0.0432 | null | null | 0.7431 | 0 | -0.252 | -0.0988 | 1.3457 | 238,036,000 | 1.2164 | 4,436,000 | 0.0227 | 4.0699 | 0.3393 | -19,341,000 | 0 | 0.1669 | -0.0389 | null | null | null | null | CY2026Q2I | 2,025 | 352,700,000 | 327,396,000 | 80,444,000 | 13,352,000 | 263,340,000 | null | 8,916,000 | false | 89,360,000 | 41,593,256 | 35,643,669 | CY2023Q2I | -38.9 | -27.5 | -48.6 | -48,191,000 | -15,511,000 | 3,830,000 | null | null | null | 134,479,000 | 139,927,000 | 0 | 117,951.12 | 0 | 2026-02-25T00:00:00 | 0001193125-26-071775 | 10-K | https://www.sec.gov/Archives/edgar/data/1111485/000119312526071775/rxst-20251231.htm | null | |||||
2026-11-04T00:00:00 | 1 | KROS | Keros Therapeutics, Inc. | 1,664,710 | Nasdaq | Pharmaceutical Preparations | 82.4 | 0.7919 | 0.8284 | 0.7848 | 0.729 | 0.6 | Rating lowered, hold; Phase II start gives modest hope | null | [
"share count shrinking +4"
] | [
"earnings inconsistent",
"debt not tagged in XBRL: estimated from non-current liabilities",
"P/E under 3: check for one-off gains",
"net income well above operating profit"
] | 10.97 | 217,504,252.36 | -26,974,747.64 | -0.8444 | -0.3644 | 70.48 | 21.69 | 10.06 | 0.0905 | 2.4996 | null | 0.8292 | 0.4001 | null | 0.4871 | 1.206 | 241,603,000 | 1.1108 | 244,479,000 | 1.124 | 21.9603 | 0.0964 | 105,954,000 | 1 | -0.3316 | null | 1.7241 | null | null | null | CY2026Q2I | 2,025 | 287,600,000 | 266,883,000 | 12,153,000 | 257,606,000 | 262,320,000 | null | 13,127,000 | false | 25,280,000 | 19,827,188 | 29,663,192 | CY2023Q2I | 87,014,000 | -187,353,000 | -152,992,000 | 67,569,000 | 107,505,000 | 1,551,000 | 375,000,000 | null | null | 243,864,000 | 0 | 0 | 0 | 1 | 2026-03-04T00:00:00 | 0001664710-26-000018 | 10-K | https://www.sec.gov/Archives/edgar/data/1664710/000166471026000018/kros-20251231.htm | WATCH | 45 | fortress | medium | Cash‑rich but still a pre‑revenue biotech; watch for trial readouts and dilution risk | |
2026-11-04T00:00:00 | 2 | SIGA | SIGA TECHNOLOGIES INC | 1,010,086 | Nasdaq | Pharmaceutical Preparations | 75.4 | 0.7057 | 0.9532 | 0.758 | 0.621 | 0.3 | Shares above 50‑day MA, limited news | null | [] | [
"revenue -32% y/y"
] | 3.15 | 226,326,605.4 | 111,343,006.4 | -0.7006 | -0.6196 | 10.52 | 6.79 | 3 | 0.05 | 9.7223 | 4.6976 | 1.3693 | 0.1029 | 0.2129 | 0.1921 | 0.7303 | 159,931,631 | 0.7066 | 114,983,599 | 0.508 | 21.7172 | 0.0632 | 43,471,453 | 3 | 0.0108 | -0.3182 | 0 | 0.1905 | 0.0051 | null | CY2026Q2I | 2,025 | 175,736,786 | 170,377,782 | 7,845,306 | 117,584,444 | 165,290,635 | 898,334 | 2,600,845 | false | 10,446,151 | 71,849,716 | 71,082,944 | CY2023Q2I | 23,279,143 | 59,214,216 | 68,068,826 | 23,702,156 | 43,471,453 | null | 0 | 43,116,529 | null | 94,574,902 | 138,719,350 | 0 | 0 | 0 | 2026-03-10T00:00:00 | 0001437749-26-007557 | 10-K | https://www.sec.gov/Archives/edgar/data/1010086/000143774926007557/siga20251231_10k.htm | WATCH | 55 | fortress | medium | Cash‑rich, single‑product govt play—big upside if contract rolls, but regulatory and renewal risk loom. | |
2026-11-04T00:00:00 | 3 | CRTO | Criteo S.A. | 1,576,427 | Nasdaq | Services-Advertising Agencies | 68.9 | 0.7677 | 0.617 | 0.5093 | 0.522 | 0.55 | Q3 pressure, growth concerns despite new clients | null | [
"share count shrinking +4"
] | [] | 14.96 | 733,003,482.64 | 649,705,482.64 | -0.6966 | -0.2797 | 49.3 | 22.88 | 14.65 | 0.0212 | 4.9195 | 3.2042 | 0.6501 | 0.2033 | 0.3121 | 0.2844 | 1.5382 | 26,419,000 | 0.036 | 83,298,000 | 0.1136 | 1.2883 | 0.7509 | 208,498,000 | 3 | -0.1221 | 0.006 | 0.2075 | null | 0.2645 | 0 | CY2026Q2I | 2,025 | 2,010,784,000 | 873,072,000 | 677,715,000 | 252,236,000 | 1,127,515,000 | 531,794,000 | 168,938,000 | false | 846,653,000 | 48,997,559 | 55,812,266 | CY2023Q2I | 149,000,000 | 115,000,000 | 55,000,000 | 202,765,000 | 311,237,000 | 102,739,000 | 152,064,000 | null | 0 | 1,944,901,000 | 1,933,289,000 | 0 | 642,246.33 | 0 | 2026-02-26T00:00:00 | 0001576427-26-000014 | 10-K | https://www.sec.gov/Archives/edgar/data/1576427/000157642726000014/crto-20251231.htm | WATCH | 55 | solid | medium | Deeply discounted ad tech with cash moat, but flat growth and execution risk keep it cautious. | |
2026-11-04T00:00:00 | 4 | USNA | USANA HEALTH SCIENCES INC | 896,264 | NYSE | Medicinal Chemicals & Botanical Products | 67.7 | 0.6237 | 0.8383 | 0.5383 | 0.587 | 0.7 | Q3 loss, revenue miss, stock down 15% | null | [] | [] | 14.14 | 261,258,190.76 | 119,260,190.76 | -0.7362 | -0.2632 | 53.6 | 22.53 | 13.37 | 0.0576 | 24.2805 | 3.186 | 0.4964 | 0.0412 | 0.3139 | 0.0326 | 2.0145 | 148,829,000 | 0.5697 | 141,998,000 | 0.5435 | 2.6597 | 0.2513 | 8,526,000 | 3 | -0.0428 | 0.0828 | 0.1053 | null | 0.1552 | 0 | CY2026Q2I | 2,025 | 703,210,000 | 281,066,000 | 105,675,000 | 168,560,000 | 526,306,000 | 109,141,000 | 26,562,000 | false | 132,237,000 | 18,476,534 | 19,301,730 | CY2023Q2I | 10,760,000 | 42,030,000 | 63,788,000 | 37,432,000 | 22,349,000 | 13,823,000 | 27,507,000 | null | 0 | 925,257,000 | 854,503,000 | 0 | 426,891.595 | 0 | 2026-03-16T00:00:00 | 0000896264-26-000021 | 10-K | https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm | WATCH | 55 | fortress | medium | Cash‑rich, cheap but China‑centric direct‑selling risks keep it a cautious watch. | |
2026-11-04T00:00:00 | 5 | AMPY | Amplify Energy Corp. | 1,533,924 | NYSE | Crude Petroleum & Natural Gas | 67.2 | 0.7951 | 0.5702 | 0.4554 | 0.409 | 0.3 | Small price gain, no major catalysts | null | [
"insider buying +6"
] | [
"debt not tagged in XBRL: estimated from non-current liabilities"
] | 3.53 | 146,341,268.5 | 211,857,268.5 | -0.5469 | -0.3414 | 7.79 | 6.56 | 3.53 | 0 | 3.3284 | 2.7535 | 0.3333 | 0.3004 | 0.3632 | 0.3362 | 3.0004 | -71,298,000 | -0.4872 | -65,516,000 | -0.4477 | 1.3069 | 0.312 | 49,200,000 | 3 | 0.0613 | -0.1063 | null | null | null | null | CY2026Q2I | 2,025 | 576,094,000 | 65,709,000 | 50,279,000 | 21,212,000 | 439,087,000 | null | 86,728,000 | false | 137,007,000 | 41,456,450 | 39,062,303 | CY2023Q2I | 43,968,000 | 12,946,000 | 392,750,000 | 76,940,000 | 49,200,000 | null | null | null | null | 263,361,000 | 294,681,000 | 98,750 | 0 | 1 | 2026-03-09T00:00:00 | 0001104659-26-025299 | 10-K | https://www.sec.gov/Archives/edgar/data/1533924/000110465926025299/ampy-20251231x10k.htm | AVOID | 15 | stretched | high | Deeply discounted but burdened by debt, shrinking reserves and high commodity risk. | |
2026-11-04T00:00:00 | 6 | NUS | NU SKIN ENTERPRISES, INC. | 1,021,561 | NYSE | Wholesale-Drugs, Proprietaries & Druggists' Sundries | 66.5 | 0.7665 | 0.4993 | 0.7356 | 0.695 | 0.6 | Turnaround lagging, skeptical outlook | null | [] | [
"P/E under 3: check for one-off gains"
] | 5.01 | 243,869,936.34 | 267,890,936.34 | -0.742 | -0.4792 | 19.42 | 11.54 | 4.58 | 0.0939 | 1.5222 | 4.0736 | 0.4493 | 0.6569 | 0.2455 | 0.1887 | 2.2255 | -70,642,000 | -0.2897 | -24,021,000 | -0.0985 | 1.9823 | 1.0664 | 46,009,000 | 2 | -0.0257 | -0.1426 | 0.0822 | null | 0.0042 | 0 | CY2026Q2I | 2,025 | 1,121,530,000 | 508,149,000 | 256,347,000 | 189,643,000 | 542,739,000 | 4,750,000 | 213,664,000 | true | 578,791,000 | 48,676,634 | 49,958,985 | CY2023Q2I | 160,204,000 | -146,594,000 | 8,595,000 | 65,763,000 | 80,286,000 | 34,277,000 | 20,040,000 | null | 0 | 1,485,159,000 | 1,732,084,000 | 0 | 18,009.48 | 0 | 2026-02-13T00:00:00 | 0001140361-26-005130 | 10-K | https://www.sec.gov/Archives/edgar/data/1021561/000114036126005130/ef20060638_10k.htm | AVOID | 15 | stretched | high | Cheap price but fragile earnings, leverage and MLM risks outweigh cash cushion. | |
2026-11-04T00:00:00 | 7 | IMXI | International Money Express, Inc. | 1,683,695 | Nasdaq | Services-Business Services, NEC | 64 | 0.5543 | 0.6128 | 0.6057 | 0.649 | 0.75 | Regulatory halt, merger doubts, shares drop 8.5% | null | [
"share count shrinking +4"
] | [] | 8.37 | 252,871,317.99 | 216,049,317.99 | -0.6334 | -0.4457 | 22.83 | 15.94 | 8.37 | 0 | 7.7399 | 3.8823 | 1.4914 | 0.1292 | 0.2576 | 0.0625 | 0.6705 | 5,646,000 | 0.0223 | 36,822,000 | 0.1456 | 1.9594 | 1.652 | 15,813,000 | 3 | -0.147 | null | 0.0646 | null | 0.1201 | 0 | CY2026Q2I | 2,025 | 449,641,000 | 285,737,000 | 145,831,000 | 150,636,000 | 169,550,000 | 53,986,000 | 113,814,000 | true | 280,091,000 | 30,211,627 | 35,418,293 | CY2023Q2I | 32,671,000 | 58,821,000 | 59,515,000 | 55,650,000 | 36,887,000 | 21,074,000 | 16,334,000 | null | 0 | null | null | 0 | 0 | 0 | 2026-03-06T00:00:00 | 0001628280-26-015647 | 10-K | https://www.sec.gov/Archives/edgar/data/1683695/000162828026015647/imxi-20251231.htm | WATCH | 55 | solid | medium | Deep‑discounted remittance player with cash cushion but merger and regulatory headwinds | |
2026-11-04T00:00:00 | 8 | VITL | Vital Farms, Inc. | 1,579,733 | Nasdaq | Food and Kindred Products | 63.1 | 0.4472 | 0.5277 | 0.8683 | 0.758 | 0.5 | losses and short‑seller pressure | null | [
"insider buying +7"
] | [] | 10.755 | 461,776,787.55 | 495,459,787.55 | -0.7896 | -0.6658 | 51.12 | 34.3 | 8.4 | 0.2804 | 6.9671 | 5.6065 | 1.6474 | 0.1435 | 0.1784 | -0.1045 | 0.607 | -75,807,000 | -0.1642 | -33,683,000 | -0.0729 | 1.5631 | 1.034 | -48,235,000 | 3 | 0.0412 | 0.2526 | null | null | 0.0068 | null | CY2026Q3I | 2,025 | 570,151,000 | 214,033,000 | 136,930,000 | 83,952,000 | 280,311,000 | 3,858,000 | 117,635,000 | true | 289,840,000 | 42,936,010 | 41,237,544 | CY2023Q2I | 66,280,000 | 53,390,000 | 25,570,000 | 88,373,000 | 33,715,000 | 81,950,000 | null | null | null | 759,444,000 | 606,307,000 | 199,187.04 | 0 | 11 | 2026-02-26T00:00:00 | 0001193125-26-073423 | 10-K | https://www.sec.gov/Archives/edgar/data/1579733/000119312526073423/vitl-20251228.htm | AVOID | 15 | solid | high | Premium egg brand looks cheap but faces structural headwinds and cash‑draining expansion. | |
2026-11-04T00:00:00 | 9 | HDSN | HUDSON TECHNOLOGIES INC /NY | 925,528 | Nasdaq | Wholesale-Machinery, Equipment & Supplies | 63.1 | 0.4968 | 0.5702 | 0.6196 | 0.674 | 0.8 | Q3 sales miss and margin squeeze | null | [
"insider buying +8",
"share count shrinking +4"
] | [
"profits not backed by cash flow"
] | 4.445 | 187,083,591.415 | 172,774,591.415 | -0.7005 | -0.3454 | 14.84 | 7.48 | 4.31 | 0.0313 | 11.2248 | 9.3095 | 0.7691 | 0.0891 | 0.1074 | -0.0439 | 1.3003 | 139,354,000 | 0.7449 | 14,309,000 | 0.0765 | 3.2315 | 0.3239 | -8,214,000 | 3 | -0.0728 | null | 0.107 | null | 0.2027 | null | CY2026Q2I | 2,025 | 322,063,000 | 218,153,000 | 67,508,000 | 25,600,000 | 243,264,000 | 65,282,000 | 11,291,000 | false | 78,799,000 | 42,088,547 | 45,395,085 | CY2023Q2I | 16,667,000 | 24,388,000 | 52,247,000 | 18,559,000 | -3,162,000 | 5,052,000 | 20,014,000 | null | null | null | 237,118,000 | 900,705.47 | 0 | 9 | 2026-03-16T00:00:00 | 0001104659-26-028445 | 10-K | https://www.sec.gov/Archives/edgar/data/925528/000110465926028445/hdsn-20251231x10k.htm | WATCH | 55 | solid | medium | Cheap, cash‑rich refrigerant specialist facing commodity and regulatory headwinds. | |
2026-11-04T00:00:00 | 10 | SMPL | Simply Good Foods Co | 1,702,744 | Nasdaq | Food and Kindred Products | 62.7 | 0.4774 | 0.7191 | 0.56 | 0.602 | 0.7 | weak sales, overvaluation | null | [
"share count shrinking +4"
] | [] | 13.21 | 1,147,446,584.07 | 1,356,240,584.07 | -0.6834 | -0.3311 | 41.72 | 21.4 | 9.6 | 0.376 | 11.0742 | 8.6447 | 0.79 | 0.0903 | 0.1157 | 0.1376 | 1.2658 | -150,796,000 | -0.1314 | -208,794,000 | -0.182 | 5.5744 | 0.4023 | 157,915,000 | 3 | -0.1274 | 0.0898 | 0.0443 | null | 0.271 | 0.0015 | CY2026Q3I | 2,025 | 2,036,744,000 | 433,540,000 | 77,773,000 | 138,425,000 | 1,452,408,000 | 551,974,000 | 347,219,000 | true | 584,336,000 | 86,861,967 | 99,548,989 | CY2023Q2I | 103,614,000 | 139,309,000 | 133,575,000 | 156,887,000 | 178,457,000 | 20,542,000 | 50,886,000 | null | 1,713,000 | 1,450,920,000 | 1,331,321,000 | 0 | 0 | 1 | 2026-10-27T00:00:00 | 0001702744-26-000031 | 10-K | https://www.sec.gov/Archives/edgar/data/1702744/000170274426000031/atk-20260829.htm | WATCH | 45 | solid | medium | Cheap, cash‑rich snack maker but brand‑driven sales slump raises a medium‑risk flag. | |
2026-11-04T00:00:00 | 11 | BYRN | Byrna Technologies Inc. | 1,354,866 | Nasdaq | Miscellaneous Electrical Machinery, Equipment & Supplies | 61.5 | 0.4337 | 0.5631 | 0.9634 | 0.914 | 0.8 | Revenue miss and widening loss scares investors | null | [
"insider buying +6"
] | [
"profits not backed by cash flow"
] | 4.178 | 97,785,062.212 | 90,566,062.212 | -0.8741 | -0.7582 | 33.18 | 19.67 | 3.34 | 0.2509 | 10.0945 | 7.6505 | 1.7741 | 0.0991 | 0.1307 | -0.094 | 0.5637 | 36,288,000 | 0.3711 | 7,219,000 | 0.0738 | 5.5356 | 0.1717 | -9,195,000 | 2 | 0.065 | 0.3774 | 0.0113 | null | 0.042 | null | CY2026Q3I | 2,025 | 64,583,000 | 45,752,000 | 8,265,000 | 8,418,000 | 55,119,000 | 2,714,000 | 1,199,000 | false | 9,464,000 | 23,404,754 | 21,977,027 | CY2023Q2I | 9,687,000 | 12,792,000 | -8,192,000 | 11,838,000 | -1,572,000 | 7,623,000 | 1,102,000 | null | null | 118,120,000 | 85,756,000 | 70,375 | 0 | 7 | 2026-02-05T00:00:00 | 0001437749-26-003206 | 10-K | https://www.sec.gov/Archives/edgar/data/1354866/000143774926003206/byrn20251130_10k.htm | null | |||||
2026-11-04T00:00:00 | 12 | LULU | lululemon athletica inc. | 1,397,187 | Nasdaq | Apparel & Other Finishd Prods of Fabrics & Similar Matl | 61.3 | 0.4564 | 0.6468 | 0.6767 | 0.654 | 0.6 | lawsuit and near-term uncertainty | null | [
"share count shrinking +4"
] | [] | 113.08 | 12,262,164,177.56 | 12,262,164,177.56 | -0.7788 | -0.3375 | 511.29 | 210.81 | 94.46 | 0.1971 | 7.7649 | 5.5469 | 2.5593 | 0.1288 | 0.1803 | 0.0752 | 0.3907 | 252,183,000 | 0.0206 | 0 | 0 | 2.19 | 0.7709 | 921,675,000 | 3 | -0.1108 | 0.0486 | 0.0961 | null | 0.0219 | 0 | CY2026Q2I | 2,025 | 8,484,578,000 | 3,945,587,000 | 1,801,651,000 | null | 4,791,174,000 | 185,840,000 | 0 | true | 3,693,404,000 | 108,437,957 | 121,949,471 | CY2023Q2I | 1,579,183,000 | 1,814,616,000 | 1,550,190,000 | 2,210,615,000 | 1,602,477,000 | 680,802,000 | 1,178,349,000 | null | 0 | 11,102,600,000 | 10,588,126,000 | 0 | 0 | 1 | 2026-03-17T00:00:00 | 0001397187-26-000020 | 10-K | https://www.sec.gov/Archives/edgar/data/1397187/000139718726000020/lulu-20260201.htm | null | |||||
2026-11-04T00:00:00 | 13 | LKQ | LKQ CORP | 1,065,696 | Nasdaq | Wholesale-Motor Vehicles & Motor Vehicle Parts & Supplies | 61.2 | 0.4646 | 0.4723 | 0.4609 | 0.563 | 0.8 | Q3 miss, CEO exit, fraud probe | null | [
"insider buying +8",
"share count shrinking +4"
] | [
"debt not tagged in XBRL: estimated from non-current liabilities"
] | 21.065 | 5,316,765,492.005 | 10,462,765,492.005 | -0.6056 | -0.3105 | 53.41 | 34.58 | 17.42 | 0.2092 | 8.7447 | 10.5365 | 0.8446 | 0.1144 | 0.0949 | 0.1593 | 1.184 | -3,203,000,000 | -0.6024 | -5,146,000,000 | -0.9679 | 1.7485 | 1.3482 | 847,000,000 | 3 | -0.0567 | -0.0124 | 0.0299 | 0.0583 | 0.3568 | -0.0002 | CY2026Q3I | 2,025 | 14,782,000,000 | 5,284,000,000 | 3,022,000,000 | 319,000,000 | 6,295,000,000 | 5,274,000,000 | 5,465,000,000 | false | 8,487,000,000 | 252,398,077 | 267,556,377 | CY2023Q2I | 608,000,000 | 693,000,000 | 938,000,000 | 993,000,000 | 1,063,000,000 | 216,000,000 | 159,000,000 | 310,000,000 | -1,000,000 | 13,651,000,000 | 13,823,000,000 | 591,530 | 0 | 2 | 2026-02-19T00:00:00 | 0001065696-26-000012 | 10-K | https://www.sec.gov/Archives/edgar/data/1065696/000106569626000012/lkq-20251231.htm | null | |||||
2026-11-04T00:00:00 | 14 | PEW | GrabAGun Digital Holdings Inc. | 2,051,380 | NYSE | Retail-Miscellaneous Shopping Goods Stores | 60.9 | 0.4557 | 0.6695 | 0.9047 | 0.753 | 0.4 | Minor price move, little substantive news | null | [] | [] | 2.08 | 61,387,951.04 | -28,459,048.96 | -0.8792 | -0.5478 | 17.22 | 4.34 | 1.84 | 0.1304 | null | null | 0.5985 | -0.0408 | null | -0.1448 | 1.6708 | 89,135,000 | 1.452 | 89,847,000 | 1.4636 | 9.4247 | 0.1868 | -8,890,000 | 2 | null | 0.0357 | null | null | null | null | CY2026Q2I | 2,025 | 121,719,000 | 108,290,000 | 11,490,000 | 97,512,000 | 102,564,000 | null | 7,665,000 | true | 19,155,000 | 29,513,438 | null | CY2023Q2I | -2,507,000 | 4,509,000 | 4,519,000 | -4,364,000 | -417,000 | 8,473,000 | null | null | null | 96,449,000 | 93,122,000 | 0 | 0 | 0 | 2026-03-12T00:00:00 | 0001193125-26-104172 | 10-K | https://www.sec.gov/Archives/edgar/data/2051380/000119312526104172/pew-20251231.htm | null | |||||
2026-11-04T00:00:00 | 15 | MDXG | MIMEDX GROUP, INC. | 1,376,339 | Nasdaq | Surgical & Medical Instruments & Apparatus | 60.2 | 0.5676 | 0.8383 | 0.7136 | 0.68 | 0.6 | profit questions after earnings | null | [] | [
"dilution 26% in 3y"
] | 3.225 | 470,610,030.975 | 349,819,030.975 | -0.6668 | -0.563 | 9.68 | 7.22 | 3.225 | 0 | 9.6877 | 5.4756 | 2.2295 | 0.1032 | 0.1826 | 0.1572 | 0.4485 | 133,763,000 | 0.2842 | 120,791,000 | 0.2567 | 4.3511 | 0.2533 | 74,003,000 | 3 | 0.2568 | 0.1999 | 0 | null | 0.0735 | null | CY2026Q3I | 2,025 | 264,552,000 | 187,233,000 | 43,031,000 | 120,791,000 | 211,082,000 | 19,441,000 | 0 | true | 53,470,000 | 145,925,591 | 116,109,125 | CY2023Q2I | 48,578,000 | 42,419,000 | 58,228,000 | 63,887,000 | 74,003,000 | null | 0 | null | null | 418,630,000 | 348,879,000 | 0 | 0 | 0 | 2026-02-25T00:00:00 | 0001376339-26-000011 | 10-K | https://www.sec.gov/Archives/edgar/data/1376339/000137633926000011/mdxg-20251231.htm | null | |||||
2026-11-04T00:00:00 | 16 | CRMD | CorMedix Inc. | 1,410,098 | Nasdaq | Pharmaceutical Preparations | 58.2 | 0.786 | 0.505 | 0.6349 | 0.654 | 0.7 | reimbursement risk and price drop | null | [] | [
"dilution 42% in 3y",
"earnings inconsistent",
"debt not tagged in XBRL: estimated from non-current liabilities",
"P/E under 3: check for one-off gains"
] | 5.635 | 439,216,265.74 | 438,347,265.74 | -0.62 | -0.4987 | 14.83 | 12.53 | 5.56 | 0.0135 | 2.6937 | 2.9196 | 0.9531 | 0.3712 | 0.3425 | 0.3934 | 1.0492 | 37,335,000 | 0.085 | 869,000 | 0.002 | 2.5644 | 0.9618 | 172,786,000 | 1 | 0.4222 | 6.1703 | null | null | 0.0332 | 0.7024 | CY2026Q2I | 2,025 | 904,052,000 | 480,554,000 | 187,396,000 | 256,692,000 | 460,833,000 | 30,002,000 | 255,823,000 | false | 443,219,000 | 77,944,324 | 54,805,376 | CY2023Q2I | 163,055,000 | -17,930,000 | -46,339,000 | 150,141,000 | 175,046,000 | 2,260,000 | null | null | 308,511,000 | 311,709,000 | 43,472,000 | 0 | 0 | 0 | 2026-03-05T00:00:00 | 0001213900-26-023889 | 10-K | https://www.sec.gov/Archives/edgar/data/1410098/000121390026023889/ea0278169-10k_cormedix.htm | null | |||||
2026-11-04T00:00:00 | 17 | PLAB | PHOTRONICS INC | 810,136 | Nasdaq | Semiconductors & Related Devices | 57.8 | 0.5257 | 0.8638 | 0.1131 | 0.229 | 0.5 | Little news, stock appears cheap | null | [
"share count shrinking +4"
] | [] | 27.83 | 1,640,959,715.34 | 1,095,339,715.34 | -0.4812 | 0.3177 | 53.64 | 53.64 | 21.06 | 0.3215 | 12.0301 | 5.262 | 1.2813 | 0.0831 | 0.19 | 0.0364 | 0.7805 | 727,815,000 | 0.4435 | 545,620,000 | 0.3325 | 4.9414 | 0.1929 | 59,661,000 | 3 | -0.0569 | -0.0204 | 0.0594 | null | null | null | CY2026Q2I | 2,025 | 1,990,743,000 | 974,856,000 | 197,283,000 | 549,513,000 | 1,280,694,000 | null | 3,893,000 | true | 247,041,000 | 58,963,698 | 62,518,181 | CY2023Q2I | 136,405,000 | 130,688,000 | 125,485,000 | 208,161,000 | 247,798,000 | 188,137,000 | 97,422,000 | null | null | 849,294,000 | 866,946,000 | 0 | 806,765 | 0 | 2025-12-17T00:00:00 | 0001140361-25-045801 | 10-K | https://www.sec.gov/Archives/edgar/data/810136/000114036125045801/ef20057458_10k.htm | null | |||||
2026-11-04T00:00:00 | 18 | UPWK | UPWORK, INC | 1,627,475 | Nasdaq | Services-Computer Processing & Data Preparation | 57.5 | 0.4574 | 0.7447 | 0.4843 | 0.429 | 0.3 | growth concerns amid AI pressure | null | [
"share count shrinking +4"
] | [] | 10.32 | 1,298,020,074.48 | 1,070,034,074.48 | -0.5332 | -0.3738 | 22.11 | 22.11 | 8.05 | 0.282 | 11.2456 | 8.2751 | 1.9847 | 0.0889 | 0.1208 | 0.1868 | 0.5039 | 290,832,000 | 0.2241 | 227,986,000 | 0.1756 | 2.251 | 0.4236 | 242,469,000 | 3 | -0.0675 | 0.024 | 0.1047 | null | 0.1602 | 0.045 | CY2026Q3I | 2,025 | 931,097,000 | 567,904,000 | 252,287,000 | 227,986,000 | 654,025,000 | 149,192,000 | 0 | true | 277,072,000 | 125,777,139 | 134,883,597 | CY2023Q2I | 115,425,000 | 215,586,000 | 46,887,000 | 129,307,000 | 248,259,000 | 5,790,000 | 135,959,000 | null | 58,406,000 | 787,784,000 | 769,325,000 | 0 | 0 | 0 | 2026-02-13T00:00:00 | 0001627475-26-000012 | 10-K | https://www.sec.gov/Archives/edgar/data/1627475/000162747526000012/upwk-20251231.htm | null | |||||
2026-11-04T00:00:00 | 19 | LFVN | Lifevantage Corp | 849,146 | Nasdaq | Pharmaceutical Preparations | 57.3 | 0.5243 | 0.5702 | 0.4796 | 0.486 | 0.5 | Little news | null | [
"insider buying +5"
] | [] | 6.01 | 75,289,361.48 | 83,584,361.48 | -0.7625 | -0.0921 | 25.31 | 9.97 | 4.15 | 0.4482 | 7.6787 | 6.8517 | 2.2415 | 0.1302 | 0.1459 | 0.1396 | 0.4461 | 9,775,000 | 0.1298 | -8,295,000 | -0.1102 | 1.8934 | 0.8491 | 10,507,000 | 3 | null | 0.1417 | 0.0418 | 0.0275 | 0.0075 | null | CY2026Q2I | 2,025 | 62,111,000 | 38,297,000 | 20,227,000 | null | 33,589,000 | 465,000 | 8,295,000 | false | 28,522,000 | 12,527,348 | null | CY2023Q2I | 9,805,000 | 2,937,000 | 2,540,000 | 12,199,000 | 11,878,000 | 1,371,000 | 3,147,000 | 2,067,000 | null | 228,530,000 | 200,164,000 | 12,130.195 | 641 | 1 | 2026-08-27T00:00:00 | 0001193125-26-371257 | 10-K | https://www.sec.gov/Archives/edgar/data/849146/000119312526371257/lfvn-20260630.htm | null | |||||
2026-11-04T00:00:00 | 20 | NAGE | Niagen Bioscience, Inc. | 1,386,570 | Nasdaq | Medicinal Chemicals & Botanical Products | 56.7 | 0.3314 | 0.7078 | 0.8877 | 0.741 | 0.4 | growth uncertainty despite pilot data | null | [] | [
"debt not tagged in XBRL: estimated from non-current liabilities"
] | 2.565 | 202,958,195.13 | 211,969,195.13 | -0.8196 | -0.6266 | 14.22 | 6.88 | 2.33 | 0.1009 | 11.6763 | 13.021 | 2.4593 | 0.0856 | 0.0768 | 0.0665 | 0.4066 | 73,725,000 | 0.3633 | -9,011,000 | -0.0444 | 6.4974 | 0.2915 | 13,504,000 | 2 | 0.0546 | 0.2995 | 0.0012 | null | null | null | CY2026Q2I | 2,025 | 106,589,000 | 97,786,000 | 15,050,000 | null | 82,528,000 | null | 9,011,000 | false | 24,061,000 | 79,126,002 | 75,032,367 | CY2023Q2I | 17,382,000 | 8,550,000 | -4,938,000 | 16,279,000 | 13,504,000 | null | 251,000 | null | null | 129,423,000 | 99,597,000 | 0 | 0 | 0 | 2026-03-04T00:00:00 | 0001386570-26-000013 | 10-K | https://www.sec.gov/Archives/edgar/data/1386570/000138657026000013/cdxc-20251231.htm | null |
End of preview. Expand in Data Studio
Plan B — Contrarian Deep-Value US Equities & AI 10-K Analysis
Plan B is a daily quantitative and fundamental research dataset covering deeply discounted, financially resilient, and heavily beaten-down US operating companies across the NYSE and Nasdaq.
Every trading day, Plan B screens the entire US equity universe (~6,000 SEC XBRL filers) using primary SEC EDGAR XBRL frames, 3-year weekly price series, SEC Form 4 open-market insider transactions, news sentiment, and LLM-synthesized 10-K/20-F deep-value investment memos.
Dataset Snapshot
| Metric | Value |
|---|---|
| Coverage Window | 2026-11-02 → 2026-11-05 (4 daily scans) |
| Unique Shortlisted Companies | 52 NYSE/Nasdaq tickers |
| Daily Ranking Observations | 160 rows (68 features per row) |
| Structured AI 10-K/20-F Memos | 15 filings analyzed |
| Open-Market Form 4 Insider Trades | 298 verified transactions |
| Update Frequency | Daily (automated post-market scan) |
| License | CC-BY-NC-4.0 (Research & Non-Commercial) |
Dataset Structure & Files
Each table is provided in both CSV (ideal for Kaggle, Pandas, R, and DuckDB) and JSON Lines (.jsonl) (ideal for Hugging Face datasets, Spark, and LLM pipelines).
| Table / Config | Files | Primary Key | Description |
|---|---|---|---|
daily_rankings (default) |
daily_rankings.csvdaily_rankings.jsonl |
(date, ticker) |
Daily ranked contrarian shortlist (~40 companies/day) with composite scores, valuation ratios, SEC XBRL balance-sheet & cash-flow fundamentals, insider totals, and AI 10-K verdict summary. |
ai_10k_memos |
ai_10k_memos.csvai_10k_memos.jsonl |
(ticker, accession) |
Skeptical value-investor memos generated from Item 1 (Business), Item 1A (Risk Factors), and Item 7 (MD&A) of each company's latest SEC Form 10-K or 20-F. |
insider_trades |
insider_trades.csvinsider_trades.jsonl |
(ticker, owner, kind, date, shares, form4_url) |
Open-market insider purchases (P) and sales (S) parsed directly from SEC Form 4 XML filings over the trailing 180 days (excluding option grants/awards). |
scan_stats |
scan_stats.csvscan_stats.jsonl |
date |
Daily universe screening funnel: total filers, usable XBRL fundamentals, priced equities, and shortlisted count. |
Screening & Ranking Methodology
Plan B follows a strict Graham–Klarman–Buffett deep-value discipline. Financial institutions (SIC 6000–6799: banks, insurers, REITs, SPACs) are excluded so balance-sheet ratios remain comparable across operating businesses.
1. Hard Quantitative Screen (Cheap + Safe + Hated)
A company must pass all three pillars simultaneously:
- Cheap: P/E ≤ 12, or EV/EBIT ≤ 8, or trading below Net Current Asset Value (
NCAV / Market Cap ≥ 1.0, a classic Benjamin Graham net-net). - Safe: Positive stockholders' equity, current ratio ≥ 1.2, total liabilities ≤ 2.0× equity (or net cash position), 3-year share dilution ≤ 25%, and positive operating cash flow if net income is negative.
- Hated: Share price down at least 40% from its 3-year weekly high (
dd_3y ≤ -0.40), with market cap ≥ $50M and share price ≥ $1.00.
2. Composite Score (0–100)
- Base Weighting: 40% Cheap (
cheap_score) + 30% Safe (safe_score) + 30% Hated (hated_score, blending price drawdown and headline negativitynews_neg). - Bonuses: Net open-market Form 4 insider buying (up to +12 pts) and 3-year share count reduction via buybacks (+4 pts).
- Penalties: Share dilution, negative free cash flow, accrual divergence (net income significantly exceeding operating cash flow or operating income), one-off profits following consecutive loss years, and high goodwill/M&A intensity.
- AI 10-K Adjustment: After reading the 10-K filing, the composite score is adjusted by the AI analyst's verdict (
CONTRARIAN BUY CANDIDATE,WATCH, orAVOID) and conviction (0–100).
Quickstart Usage
Python (datasets — Hugging Face)
from datasets import load_dataset
# Load default config (daily_rankings)
rankings = load_dataset("elsiddik/planb-deep-value", "daily_rankings", split="train")
print(rankings.to_pandas()[["date", "rank", "ticker", "score", "pe", "ev_ebit", "dd_3y", "ai_verdict"]].head())
# Load structured 10-K AI memos
memos = load_dataset("elsiddik/planb-deep-value", "ai_10k_memos", split="train")
# Load Form 4 open-market insider trades
insiders = load_dataset("elsiddik/planb-deep-value", "insider_trades", split="train")
Python (pandas — Kaggle / Local CSV)
import pandas as pd
df = pd.read_csv("daily_rankings.csv")
memos = pd.read_csv("ai_10k_memos.csv")
insiders = pd.read_csv("insider_trades.csv")
# Filter highest-conviction ideas with net cash and insider buying
top_ideas = df[(df["net_cash"] > 0) & (df["insider_buy_value"] > 0)].sort_values(["date", "rank"])
print(top_ideas[["date", "ticker", "name", "score", "pe", "ev_ebit", "net_cash_pct", "ai_verdict"]].head(10))
Data Dictionary
1. daily_rankings (68 Columns)
| Column | Type | Description |
|---|---|---|
date |
string |
Scan date (YYYY-MM-DD). |
rank |
int |
Daily rank (1 = highest composite score). |
ticker, name, cik, exchange, sector |
string/int |
Ticker symbol, SEC registrant name, SEC CIK identifier, exchange (NYSE/Nasdaq), and SIC industry description. |
score |
float |
Final Plan B composite score (0–100). |
cheap_score, safe_score, hated_price_score, hated_score |
float |
Normalized sub-scores (0.0–1.0) for valuation, balance-sheet safety, price drawdown, and combined hated score. |
news_neg, hate_why |
float/string |
Headline negativity score (0.0 loved → 1.0 hated) and short explanation of market pessimism. |
first_seen, return_since_first |
string/float |
Date the ticker first entered the shortlist and cumulative price return since first_seen. |
bonus, flags |
list / string |
Score bonuses (e.g., insider buying, shrinking shares) and accounting/risk flags. |
price, mcap, ev |
float |
Latest share price (USD), market capitalization (USD), and enterprise value (Market Cap + Debt - Cash, USD). |
dd_3y, ret_1y, high_3y, high_52w, low_52w, off_low |
float |
Drawdown from 3-year high (-0.75 = down 75%), 1-year return, 3-year/52-week highs & lows, and percentage above 52-week low. |
pe, ev_ebit, pb |
float |
Price-to-Earnings, Enterprise Value-to-EBIT (capped at 0 when EV is negative), and Price-to-Book ratio. |
earnings_yield, ebit_ev, fcf_yield, book_yield |
float |
Inverse valuation yields: NI / MCap, EBIT / EV, FCF / MCap, and Equity / MCap. |
ncav, netnet, net_cash, net_cash_pct |
float |
Net Current Asset Value (CA - Total Liabilities), NCAV / MCap, Net Cash (Cash - Debt), and Net Cash / MCap. |
current_ratio, liab_eq, fcf, profit_years |
float/int |
Current assets / current liabilities, total liabilities / equity, free cash flow (CFO - CapEx), and profitable years out of the last 3 FYs (0–3). |
share_chg_3y, rev_growth, buyback_yield, div_yield, goodwill_pct, acq_pct |
float |
3-year share count change, YoY revenue growth, buybacks/MCap, dividends/MCap, goodwill/assets, and acquisitions/assets. |
period, fy, assets, ca, cl, cash, equity, goodwill, debt, debt_known, liab |
mixed |
Raw SEC XBRL balance-sheet values (USD) and reporting period (CY2026Q3I, etc.). |
shares, shares_old, shares_old_period |
float/string |
Latest common shares outstanding and shares outstanding 3 years prior. |
ni, ni_1, ni_2, oi, cfo, capex, buyback, dividends, acquisitions, rev, rev_1 |
float |
Raw SEC XBRL annual income statement and cash-flow values (USD) for the latest and prior fiscal years. |
insider_buy_value, insider_sell_value, insider_buyers_count |
float/int |
Trailing 180-day open-market Form 4 purchase USD total, sale USD total, and distinct buyer count. |
tenk_date, tenk_accession, tenk_form, tenk_url |
string |
Filing date, SEC accession number, form type (10-K / 20-F), and direct SEC EDGAR archive URL. |
ai_verdict, ai_conviction, ai_balance_sheet, ai_value_trap_risk, ai_one_liner |
mixed |
AI 10-K analyst summary fields (CONTRARIAN BUY CANDIDATE / WATCH / AVOID, conviction 0–100, balance sheet rating, value-trap risk, and one-line thesis). |
2. ai_10k_memos (21 Columns)
| Column | Type | Description |
|---|---|---|
ticker, name, cik, exchange, sector |
string/int |
Company identifiers and SIC industry classification. |
accession, filing_date, read_on, filing_url |
string |
SEC accession number, filing date, scan date analyzed, and direct EDGAR filing URL. |
verdict, conviction, balance_sheet, value_trap_risk |
string/int |
Overall verdict, conviction (0–100), balance-sheet rating (fortress/solid/stretched/weak), and value-trap risk (low/medium/high). |
one_liner, business, why_hated, capital_allocation, management |
string |
Concise investment synthesis covering the business model, market pessimism, buybacks/dividends/M&A, and leadership. |
bull, bear, red_flags |
list / string |
Bullet lists of key bull points, bear points, and accounting/governance/footnote red flags from the 10-K. |
3. insider_trades (11 Columns)
| Column | Type | Description |
|---|---|---|
date |
string |
Transaction date (YYYY-MM-DD). |
ticker, company_name, cik |
string/int |
Issuer ticker, company name, and SEC CIK. |
owner, title |
string |
Reporting insider name and relationship/officer title (CEO, CFO, Director, 10% owner). |
kind |
string |
Open-market transaction code: P (Purchase) or S (Sale). |
shares, price, value |
float |
Number of shares traded, execution price per share (USD), and total dollar value (USD). |
form4_url |
string |
Direct URL to the primary SEC Form 4 XML filing on EDGAR. |
Data Integrity, Privacy & Caveats
- Zero Credentials / Zero PII Guarantee: Every export passes an automated security gate (
assertNoCredentials) that enforces an explicit column allowlist, scrubs email addresses, and scans against secret/token patterns before writing or uploading. - XBRL Tagging Nuances: SEC fundamentals reflect company-reported US-GAAP XBRL tags. Unusual tagging or dual-class share structures can occasionally distort market cap or debt ratios; always cross-check the linked SEC filing (
tenk_url). - Research Only: This dataset is for quantitative, academic, and machine-learning research only and never constitutes financial or investment advice.
- Downloads last month
- 35